Top

Dawid Schellingerhout, MBChB, BSc (Hons) (Physiology), CPE, MBA

Department of Neuroradiology, Division of Diagnostic Imaging

About Dr. Schellingerhout

Dr. Schellingerhout joined M D Anderson in 2004 from Massachusetts General Hospital and Harvard Medical School. He regularly publishes in the molecular and neurological imaging literature, and regularly presents data at national and international scientifice meetings.

Dr. Schellingerhout’s research centers on investigating the Nervous System with molecular and novel imaging technologies. His group has developed a set of molecular imaging agents for neurography, the imaging of nerve tissue by means of molecular imaging, and has investigated several preclinical models in preparation to applying this technology to humans.

He also has a patient-centered program investigating the correlations between imaging and biological findings in patients with gliomas, in collaboration with Neurosurgery and Neuropathology, and involving advanced MR imaging directed biopsies correlated to state-of-the-art pathological and biological assessments of harvested patient brain tissues He is also investigating the clinical uses of Dual Energy CT and Phase Sensitive MR in the characterization of cerebral lesions in a human imaging trial.

Primary Appointment

Professor, Department of Imaging Physics, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX

Professor, Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Professor, Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX

Professor, Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX

Associate Member, Department of Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX

Research Interests

Molecular Imaging of novel gene and cell based therapies, particularly for Central Nervous System (CNS) conditions
Non-invasive mapping of therapeutic gene delivery
Assessment of therapeutic gene expression by imaging
Pharmacological manipulation of gene therapy vector distribution
Focus ultrasound for the disruption of the blood brain barrier
Assessment of PET agents for the delineation of brain tumors

Clinical Interests

Developing new imaging technologies and image guided therapies

Education & Training

Degree-Granting Education

2022	Rice University, Jones School of Business, Houston, Texas, US, Executive Masters of Business Administration, MBA
1994	University of Pretoria, Faculty of Medicine, Pretoria, ZA, Physiology, BSc Hons (cum laude)
1993	University of Pretoria, Faculty of Medicine, Pretoria, ZA, Medicine, MBChB

Postgraduate Training

2013-null	Certifying Commission in Medical Management, Certified Physician Executive, American College of Physician Executives, Tampa, Florida
2000-2001	Clinical Fellowship, Neuroradiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
1999-2000	Clinical Residency, Neuroradiology Focus Year, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
1996-2000	Clinical Residency, Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
1995-1996	General Practice, Cardiology/General Medicine, One Military Hospital, Pretoria
1994-1994	Clinical Internship, Surgery, Medicine, Anesthesiology, Pediatrics, One Military Hospital, Pretoria

Board Certifications

2002	American Board of Radiology, Certificate of Additional Qualification in Neuroradiology
2000	American Board of Radiology, Diagnostic Radiology (valid indefinitely)

Experience & Service

Academic Appointments

Professor, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - 2019

Associate Professor, Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - 2022

Associate Professor, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - 2018

Associate Professor, Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - 2018

Assistant Professor, Department of Experimental Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2004 - 2011

Assistant Professor, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2004 - 2011

Instructor, Department of Diagnostic Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 2001 - 2004

Administrative Appointments/Responsibilities

Director of Research, Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - 2021

Head of Schellingerhout Lab, Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2004 - Present

Other Appointments/Responsibilities

TrueFidelity image quality generated on EVO CT system, GE Healthcare, Houston, TX, 2019 - 2019

Gadolinium related T1 signal in the brain, Guerbet LLC Advisory Board, Washington, DC, 2016 - 2016

Imaging Consultant on Gliasite bradytherapy device clinical trial, Proxima Therapeutics, Orlando, FL, 2004 - 2004

Attending Radiologist, Division of Emergency Radiology, Massachusetts General Hospital, Boston, MA, 2004 - 2004

Member, Radiology Associates Nominating Committee for the Executive Committee at Massachusetts General Hospital, Boston, MA, 2003 - 2004

Attending Radiologist, Division of Neuroradiology, Massachusetts General Hospital, Boston, MA, 2001 - 2004

Research Associate, Center for Molecular Imaging Research, Massachusetts General Hospital, Boston, MA, 1996 - 2004

Medical Officer in Cardiology, Medicine and Radiology, One Military Hospital, Pretoria, 1995 - 1996

Post Graduate Student in Laboratory of Margaretha Viljoen, PhD, Department of Physiology, University of Pretoria, Pretoria, 1994 - 1995

General Medical Assistant, Pretoria Academic Hospital, Emergency Department, Pretoria, 1987 - 1992

Institutional Committee Activities

Committee Member, DI-RFC Awards & Honors Committee, 2022 - Present

Member, Photon Counting CT Task Force, 2021 - Present

Member, Diagnostic Imaging Research Functional Committee, 2021 - Present

Member, Brain Tumor Center Tissue Oversight Committee, 2021 - Present

Member, Diagnostic Imaging Promotion and Tenure Committee, 2021 - Present

Member, Brain Tumor Center, Tissue Utilization Committee, 2021 - 2021

Non Physicist Member, Medical Physics Graduate Program Steering Committee, 2018 - 2021

Member, Nuclear Medicine Faculty Search Committee, 2016 - Present

Member, Faculty Appeals Panel, 2014 - Present

Member, Diagnostic Imaging Equipment Selection Committee, 2014 - Present

Member, Imaging Physics Section Chief Search Committee, 2013 - Present

Member, MR Contrast Agent Selection Subcommittee, 2013 - Present

Member, Diagnostic Imaging Faculty Functional Committee, 2013 - 2016

Member, Nuclear Medicine Faculty Search Committee, 2011 - 2014

Member, Diagnostic Imaging Informatics Advisory Group, 2011 - Present

Member, Survivorship Research Advisory Committee, 2011 - Present

Member, MR Clinical Utilization Committee, 2008 - Present

Honors & Awards

2007	Honorary Member, Bluegrass Radiological Society
2003	Norman E. Leeds Award for presentation entitled "Molecular Imaging in Neuroradiology", Eastern Neuroradiological Society
2000	Resident Research Trainee Prize for abstract entitled: “Gene Therapy to Somatic Organs: Using imaging to assess pharmacological manipulations of viral mass distribution”, Radiological Society of North America
1994	Grant Recipient, NAVKOM D.O.O
1994	Postgraduate Degree in Physiology cum laude, University of Pretoria
1993	Medical Degree cum laude, University of Pretoria
1987	University Merit Award, University of Pretoria
1987	Graduated High School with Seven Distinctions
1986	Winner (placed 43rd countrywide), Youth Science Olympiad, South Africa

Professional Memberships

American College of Physician Executives

2011 - Present

Society for NeuroOncology

2008 - Present

Harris County Medical Association

2004 - Present

Texas Medical Association

2004 - Present

Society for Molecular Imaging

2002 - Present

American Society for Neuroradiology

2001 - Present

American Medical Association

2000 - Present

Radiological Society of North America

1996 - Present

Massachusetts Medical Society

1996 - Present

New England Roentgen Ray Society

1996 - Present

American Roentgen Ray Society

1996 - Present

Selected Publications

Peer-Reviewed Articles

Kim, H, Chung, J, Kang, JW, Schellingerhout, D, Lee, SJ, Jang, HJ, Park, I, Kim, T, Gwak, DS, Lee, JS, Hong, SH, Je, KH, Bae, HJ, Sung, J, Lo, EH, Faber, J, Ayata, C, Kim, DE. Inhibition of nitric oxide synthase transforms carotid occlusion-mediated benign oligemia into de novo large cerebral infarction. Theranostics 15(2):585-604, 2025. e-Pub 2025. PMID: 39744690.
Eldaya, R, Kaya, D, Williams, MD, Calle, S, Schellingerhout, D. Clinical and Imaging Features of Head and Neck Metastasis of High-Grade Glioma. American Journal of Neuroradiology 46(1):160-165, 2025. e-Pub 2025. PMID: 39667825.
Kim H, Ryu WS, Schellingerhout D, Park J, Chung J, Jeong SW, Gwak DS, Kim BJ, Kim JT, Hong KS, Lee KB, Park TH, Park JM, Kang K, Cho YJ, Lee BC, Yu KH, Oh MS, Lee SJ, Cha JK, Kim DH, Lee J, Park MS, Bae HJ, Kim DE. Automated segmentation of MRI white matter hyperintensities in 8,421 patients with acute ischemic stroke. AJNR Am J Neuroradiol 45(12):1885-1894, 2024. e-Pub 2024. PMID: 39013565.
Dagher SA, Liu HL, Ozkara BB, Calle S, Kaya D, Gule-Monroe MK, Chasen NN, Schellingerhout D, Learned KO, Shah KB, Johnson JM, Sun J, Schomer DF, Kumar VA, Wintermark M, Majd NK, Nam JY, Chen MM. The Impact of MRI-Based Advanced Neuroimaging on Neurooncologists' Clinical Decision-Making in Patients With Posttreatment High-Grade Glioma: A Prospective Survey-Based Study. AJR Am J Roentgenol 223(4):1-15, 2024. e-Pub 2024. PMID: 39140632.
Gwak DS, Ryu WS, Schellingerhout D, Chung J, Kim HR, Jeong SW, Kim BJ, Kim JT, Hong KS, Park JM, Park MS, Choi KH, Park TH, Lee K, Park SS, Kang K, Cho YJ, Park HK, Lee BC, Yu KH, Oh MS, Lee SJ, Kim JG, Cha JK, Kim DH, Lee J, Han MK, Lee JS, Bae HJ, Kim DE. Effects of white matter hyperintensity burden on functional outcome after mild versus moderate-to-severe ischemic stroke. Sci Rep 14(1):22567, 2024. e-Pub 2024. PMID: 39343768.
Lai SY, Sandulache VC, Schellingerhout D, Fuller CD, Chen Y, Walker CM, Bankson JA. First-in-Human Hyperpolarized MRI for Tumor Metabolism in HNSCC. JAMA Otolaryngol Head Neck Surg 150(7):628-630, 2024. e-Pub 2024. PMID: 38780963.
Ryu WS, Schellingerhout D, Lee H, Lee KJ, Kim CK, Kim BJ, Chung JW, Lim JS, Kim JT, Kim DH, Cha JK, Sunwoo L, Kim D, Suh SI, Bang OY, Bae HJ, Kim DE. Deep Learning-Based Automatic Classification of Ischemic Stroke Subtype Using Diffusion-Weighted Images. J Stroke 26(2):300-311, 2024. e-Pub 2024. PMID: 38836277.
Jha PK, Walker C, Mitchell D, Oden JT, Schellingerhout D, Bankson JA, Fuentes DT. Mutual-information based optimal experimental design for hyperpolarized C13-pyruvate MRI. Sci Rep 13(1):18047, 2023. e-Pub 2023. PMID: 37872226.
Ryu WS, Chung J, Schellingerhout D, Jeong SW, Kim HR, Park JE, Kim BJ, Kim JT, Hong KS, Lee K, Park TH, Park SS, Park JM, Kang K, Cho YJ, Park HK, Lee BC, Yu KH, Oh MS, Lee SJ, Kim JG, Cha JK, Kim DH, Lee J, Han MK, Park MS, Choi KH, Lee J, Bae HJ, Kim DE. Biological Mechanism of Sex Difference in Stroke Manifestation and Outcomes. Neurology 100(24):e2490-e2503, 2023. e-Pub 2023. PMID: 37094993.
Celaya A, Actor JA, Muthusivarajan R, Gates E, Chung C, D|| S, Riviere B, Fuentes D. PocketNet: A Smaller Neural Network For Medical Image Analysis. IEEE Trans Med Imaging PP(4):1172-1184, 2023. e-Pub 2022. PMID: 36427285.
Jang HJ, Schellingerhout D, Kim J, Chung J, Kim DE. Towards a biomarker for acute arterial thrombosis using complete blood count and white blood cell differential parameters in mice. Sci Rep 13(1):4043, 2023. e-Pub 2023. PMID: 36899036.
ENE Group MO, Sahin O, Wahid KA, Taku N, He R, Naser MA, Mohamed ASR, Mäkitie A, Kann BH, Kaski K, Sahlsten J, Jaskari J, Amit M, Chen MM, Chronowski GM, Diaz EM, Garden AS, Goepfert RP, Guenette JP, Gunn GB, Hirvonen J, Hoebers F, Guha-Thakurta N, Johnson J, Kaya D, Khanpara SD, Nyman K, Lai SY, Lango M, Learned KO, Lee A, Lewis CM, Maniakas A, Moreno AC, Myers JN, Phan J, Pytynia KB, Rosenthal DI, Sandulache V, Schellingerhout D, Shah SJ, Sikora AG, Wintermark M, Fuller CD. Multi-Specialty Expert Physician Identification of Extranodal Extension in Computed Tomography Scans of Oropharyngeal Cancer Patients: Prospective Blinded Human Inter-Observer Performance Evaluation. medRxiv, 2023. e-Pub 2023. PMID: 36865096.
Kang DW, Park GH, Ryu WS, Schellingerhout D, Kim M, Kim YS, Park CY, Lee KJ, Han MK, Jeong HG, Kim DE. Strengthening deep-learning models for intracranial hemorrhage detection: strongly annotated computed tomography images and model ensembles. Front Neurol 14:1321964, 2023. e-Pub 2023. PMID: 38221995.
Gates EDH, Suki D, Celaya A, Weinberg JS, Prabhu SS, Sawaya R, Huse JT, Long JP, Fuentes D, Schellingerhout D. Cellular Density in Adult Glioma, Estimated with MR Imaging Data and a Machine Learning Algorithm, Has Prognostic Power Approaching World Health Organization Histologic Grading in a Cohort of 1181 Patients. AJNR Am J Neuroradiol 43(10):1411-7, 2022. e-Pub 2022. PMID: 36109124.
Gates EDH, Celaya A, Suki D, Schellingerhout D, Fuentes D. An efficient magnetic resonance image data quality screening dashboard. J Appl Clin Med Phys 23(4):e13557, 2022. e-Pub 2022. PMID: 35148034.
Debnam JM, Chi TL, Kwon M, Sun J, Schellingerhout D, Golant BT, Ahmed S, Perrier ND, Vu T. Distinguishing Intrathyroid Parathyroid Adenoma from Colloid Nodules and Papillary Thyroid Carcinomas Using Multiphasic Multidetector Computed Tomography. J Comput Assist Tomogr 46(5):808-814, 2022. e-Pub 2022. PMID: 36103680.
Ryu WS, Schellingerhout D, Hong KS, Jeong SW, Kim BJ, Kim JT, Lee KB, Park TH, Park SS, Park JM, Kang K, Cho YJ, Park HK, Lee BC, Yu KH, Oh MS, Lee SJ, Kim JG, Cha JK, Kim DH, Lee J, Han MK, Park MS, Choi KH, Nahrendorf M, Lee J, Bae HJ, Kim DE. Relation of Pre-Stroke Aspirin Use With Cerebral Infarct Volume and Functional Outcomes. Ann Neurol 90(5):763-776, 2021. e-Pub 2021. PMID: 34536234.
Baiomy A, Schellingerhout D, Chapin B, Weinberg JS, Raza SM, Macapinlac H, Ravizzini G. Rate of Incidental Central Nervous System Meningioma Detected in Patients Undergoing 18F-fluciclovine PET/CT Imaging for Evaluation of Prostate Cancer. Nucl Med Commun 42(7):755-762, 2021. e-Pub 2021. PMID: 33741867.
Schellingerhout D, Jacobsen M, Le Roux L, Johnson JM, Baladandayuthapani V, Hwang K, Hazle J, Cody D. The Calcium vs Hemorrhage Trial: Developing Diagnostic Criteria for Chronic Intracranial Susceptibility Lesions Using Single Energy CT, Dual Energy CT, and Quantitative Susceptibility Mapping. Invest Radiol 56(6):385-393, 2021. e-Pub 2021. PMID: 33534507.
Gates EDH, Weinberg JS, Prabhu SS, Lin JS, Hamilton J, Hazle JD, Fuller GN, Baladandayuthapani V, Fuentes DT, Schellingerhout D. Estimating Local Cellular Density in Glioma Using MR Imaging Data. AJNR Am J Neuroradiol 42(1):102-108, 2021. e-Pub 2021. PMID: 33243897.
Kim J, Jang HJ, Schellingerhout, Lee SK, Kim H, Kim YD, Lee KY, Choi HY, Cho HJ, Jang SS, Jeon S, Kwon IC, Kim K, Ryu WI, Nathrendorf M, Choi S, Kim DE. Short-term Cessation of Dabigatran Causes a Paradoxical Prothrombotic State. Annals of Neurology 89(3):444-458, 2020. e-Pub 2020. PMID: 33219556.
Le Roux LG, Qiu X, Jacobsen MC, Pagel MD, Gammon ST, Piwnica-Worms DR, Schellingerhout D. Axonal transport as an in vivo biomarker for retinal neuropathy. Cells 9(5):1298, 2020. e-Pub 2020. PMID: 32456061.
Elshikh M, Schellingerhout D, Rayan J, Taher A, Elsayes AK, Mujtaba B, Garg N. Disease Characteristics, Radiologic Patterns, Comorbid Diseases, and Ethnic Differences in 32 Patients With Rosai-Dorfman Disease. J Comput Assist Tomogr 44(3):450-461, 2020. e-Pub 2020. PMID: 31972751.
Debnam JM, Guha-Thakurta N, Sun J, Wei W, Zafereo ME, Cabanillas ME, Buisson NM, Schellingerhout D. Distinguishing Recurrent Thyroid Cancer from Residual Nonmalignant Thyroid Tissue Using Multiphasic Multidetector CT. AJNR Am J Neuroradiol, 2020. e-Pub 2020. PMID: 32327435.
Kim J, Jang HJ, Schellingerhout D, Kang JW, Choi S, Oh H, Kim EJ, Lee SK, Lee JS, Kwon IC, Kim K, Koh YJ, Ryu WS, Kim DE. Effects of exercise training and detraining on atheromatous matrix metalloproteinase activity in mice. Atherosclerosis, 2020. e-Pub 2020. PMID: 32182440.
Gates EDH, Lin JS, Weinberg JS, Prabhu SS, Hamilton J, Hazle JD, Fuller GN, Baladandayuthapani V, Fuentes DT, Schellingerhout D. Imaging-Based Algorithm for the Local Grading of Glioma. AJNR Am J Neuroradiol, 2020. e-Pub 2020. PMID: 32029466.
Kim J, Lee SK, Schellingerhout D, Nahrendorf M, Kim K, Kim J, Kim DE. Spectroscopic Assessment of Gold Nanoparticle Biodistribution Using Surface Plasmon Resonance Phenomena. ACS Biomater Sci Eng 5(12):6389-6394, 2019. e-Pub 2019. PMID: 33417791.
Michel KA, Zieliński R, Walker CM, Le Roux L, Priebe W, Bankson JA, Schellingerhout D. Hyperpolarized Pyruvate MR Spectroscopy Depicts Glycolytic Inhibition in a Mouse Model of Glioma. Radiology, 2019. e-Pub 2019. PMID: 31385757.
Kim DE, Schellingerhout D, Ryu WS, Park JH, Lee SK, Kim D, Bae HJ. Supratentorial Cerebral Arterial Territories for Computed Tomograms: A Mapping Study in 1160 Large Artery Infarcts. Sci Rep 9(1):11708, 2019. e-Pub 2019. PMID: 31406206.
Ryu WS, Schellingerhout D, Ahn HS, Park SH, Hong KS, Jeong SW, Park MS, Choi KH, Kim JT, Kim BJ, Han MK, Lee J, Cha JK, Kim DH, Nah HW, Lee SJ, Cho YJ, Lee BC, Yu KH, Oh MS, Park JM, Kang K, Lee KB, Park TH, Park SS, Smith EE, Lee J, Bae HJ, Kim DE. White matter hyperintensity load on stroke recurrence and mortality at 1 year after ischemic stroke. Neurology 93(6):e578-e589, 2019. e-Pub 2019. PMID: 31308151.
Jacobsen MC, Cressman ENK, Tamm EP, Baluya DL, Duan X, Cody DD, Schellingerhout D, Layman RR. Dual-Energy CT: Lower Limits of Iodine Detection and Quantification. Radiology 292(2):414-419, 2019. e-Pub 2019. PMID: 31237496.
Gates EDH, Yang J, Fukumura K, Lin JS, Weinberg JS, Prabhu SS, Long L, Fuentes D, Sulman EP, Huse JT, Schellingerhout D. Spatial Distance Correlates With Genetic Distance in Diffuse Glioma. Front Oncol 9:676, 2019. e-Pub 2019. PMID: 31417865.
Kennis BA, Michel KA, Brugmann WB, Laureano A, Tao RH, Somanchi SS, Einstein SA, Bravo-Alegria JB, Maegawa S, Wahba A, Kiany S, Gordon N, Silla L, Schellingerhout D, Khatua S, Zaky W, Sandberg D, Cooper L, Lee DA, Bankson JA, Gopalakrishnan V. Correction to: Monitoring of intracerebellarly-administered natural killer cells with fluorine-19 MRI. J Neurooncol 142(3):409, 2019. e-Pub 2019. PMID: 30968268.
Gates EDH, Lin JS, Weinberg JS, Hamilton J, Prabhu SS, Hazle JD, Fuller GN, Baladandayuthapani V, Fuentes D, Schellingerhout D. Guiding the first biopsy in glioma patients using estimated Ki-67 maps derived from MRI: conventional versus advanced imaging. Neuro-Oncology 21(4):527-536, 2019. e-Pub 2019. PMID: 30657997.
Vu TH, Schellingerhout D, Guha-Thakurta N, Sun J, Wei SW, Kappadath C, Perrier N, Kim EE, Rohren E, Chuang HH, Wong FC. Solitary Parathyroid Adenoma Localization inTechnetium Tc99m Sestamibi SPECT CT and Multiphase Multidetector 4D CT. AJNR 40(1):142-149, 2019. e-Pub 2019. PMID: 30523145.
Kim DE, Park JH, Schellingerhout D, Rye WS, Lee SK, Jang MU, Jeong SW, Na JY, Park JE, Lee EJ, Cho KH, Kim JT, Kim BJ, Han MK, Lee J, Cha JK, Kim DH, Lee SJ, Ko Y, Lee BC, Yu KH, Oh MS, Hong KS, Cho YJ, Park JM, Kang K, Park TH, Lee KB, Park KJ, Choi HK, Lee JY, Bae HJ. Supratentorial Cerebral Arterial Territories: A Mapping Study in 1160 Large Artery Infarcts. JAMA Neurol 76(1):72-80, 2019. e-Pub 2019. PMID: 30264158.
Kim DE, Ryu WS, Schellingerhout D, Jeong HG, Kim P, Jeong SW, Park MS, Choi KH, Kim JT, Kim BJ, Han MK, Lee J, Cha JK, Kim DH, Nah HW, Lee SJ, Kim JG, Hong KS, Cho YJ, Park HK, Lee BC, Yu KH, Oh MS, Park JM, Kang K, Lee KB, Park TH, Park SS, Lee YS, Bae HJ. Estimation of Acute Infarct Volume with Reference Maps: A Simple Visual Tool for Decision Making in Thrombectomy Cases. Journal of Stroke 21(1):69-77, 2019. e-Pub 2019. PMID: 30732442.
Ryu WS, Schellingerhout D, Ahn HS, Park SH, Hong KS, Jeong SW, Park MS, Choi KH, Kim JT, Kim BJ, Han MK, Lee J, Cha JK, Kim DH, Nah HW, Lee SJ, Cho YJ, Lee BC, Yu KH, Oh MS, Park JM, Kang K, Lee KB, Park TH, Park SS, Smith EE, Lee J, Bae HJ, Kim DE. Hemispheric Asymmetry of White Matter Hyperintensity in Association With Lacunar Infarction. Journal of The American Heart Association 7(22):e010653, 2018. e-Pub 2018. PMID: 30571500.
Jacobsen MC, Schellingerhout D, Wood CA, Tamm EP, Godoy MC, Sun J, Cody DD. Intermanufacturer comparison of dual-energy computed tomography iodine quantification and monochromatic attenuation: a phantom study. Radiology 287(1):170896, 2018. e-Pub 2018. PMID: 29185902.
Ryu WS, Bae EK, Park SH, Jeong SW, Schellingerhout D, Nahrendorf M, Kim DE. Increased Left Ventricular Filling Pressure and Arterial Occlusion in Stroke Related to Atrial Fibrillation. J Stroke Cerebrovasc Dis. e-Pub 2018. PMID: 29310958.
Shon SM, Jang HJ, Schellingerhout D, Kim JY, Ryu WS, Lee SK, Kim J, Park JY, Oh JH, Kang JW, Je KH, Park JE, Kim K, Kwon IC, Lee J, Nahrendorf M, Park JH, Kim DE. Cytokine Response to Diet and Exercise Affects Atheromatous Matrix Metalloproteinase-2/9 Activity in Mice. Circ J 81(10):1528-1536, 2017. e-Pub 2017. PMID: 28883215.
Kim DE, Kim JY, Schellingerhout D, Ryu JH, Lee SK, Jeon S, Lee JS, Kim J, Jang HJ, Park JE, Kim EJ, Kwon IC, Ahn CH, Nahrendorf M, Kim K. Quantitative Imaging of Cerebral Thromboemboli In Vivo: The Effects of Tissue-Type Plasminogen Activator. Stroke 48(5):1376-1385, 2017. e-Pub 2017. PMID: 28432262.
Lin JS, Fuentes DT, Chandler A, Prabhu SS, Weinberg JS, Baladandayuthapani V, Hazle JD, Schellingerhout D. Performance Assessment for Brain MR Imaging Registration Methods. AJNR Am J Neuroradiol 38(5):973-980, 2017. e-Pub 2017. PMID: 28279984.
Je KH, Ryu WS, Lee SK, Kim EJ, Kim JY, Jang HJ, Park JE, Nahrendorf M, Schellingerhout D, Kim DE. Green-channel autofluorescence imaging: A novel and sensitive technique to delineate infarcts. J Neurosci Methods 279:22-32, 2017. e-Pub 2017. PMID: 28104485.
Li CH, Chen FH, Schellingerhout D, Lin YS, Hong JH, Liu HL. Flow versus permeability weighting in estimating the forward volumetric transfer constant (Ktrans) obtained by DCE-MRI with contrast agents of differing molecular sizes. Magn Reson Imaging 36:105-111, 2017. e-Pub 2017. PMID: 27989901.
Ryu WS, Woo SH, Schellingerhout D, Jang MU, Park KJ, Hong KS, Jeong SW, Na JY, Cho KH, Kim JT, Kim BJ, Han MK, Lee J, Cha JK, Kim DH, Lee SJ, Ko Y, Cho YJ, Lee BC, Yu KH, Oh MS, Park JM, Kang K, Lee KB, Park TH, Lee J, Choi HK, Lee K, Bae HJ, Kim DE. Stroke outcomes are worse with larger leukoaraiosis volumes. Brain 140(Pt 1):158-170, 2017. e-Pub 2017. PMID: 28008000.
Nute JL, Jacobsen MC, Chandler A, Cody DD, Schellingerhout D. Dual-energy computed tomography for the characterization of intracranial hemorrhage and calcification: a systematic approach in a phantom system. Invest Radiol 52(1):30-41, 2017. e-Pub 2017. PMID: 27379697.
Shah AR, Muzzafar T, Assi R, Schellingerhout D, Estrov Z, Tamamyan G, Kantarjian H, Daver N. Hemophagocytic lymphohistiocytosis in adults: An under recognized entity. BBA Clin 7:36-40, 2016. e-Pub 2016. PMID: 28070498.
Kim DE, Kim JY, Lee SK, Ryu JH, Kwon IC, Ahn CH, Kim K, Schellingerhout D. Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli. J Vis Exp 25(115), 2016. e-Pub 2016. PMID: 27768026.
Ryu WS, Schellingerhout D, Jeong SW, Nahrendorf M, Kim DE. Association between Serum Lipid Profiles and Early Neurological Deterioration in Acute Ischemic Stroke. J Stroke Cerebrovasc Dis 25(8):2024-2030, 2016. e-Pub 2016. PMID: 27256172.
Muzzafar S, Rhines LD, Bruner J, Schellingerhout D. Intradural extramedullary Ewing tumor of the lumbar spine. Radiol Case Rep 5(4):421, 2015. e-Pub 2015. PMID: 27307878.
Bankson JA, Walker CM, Ramirez MS, Stefan W, Fuentes D, Merritt ME, Lee J, Sandulache VC, Chen Y, Phan L, Chou PC, Rao A, Yeung SC, Lee MH, Schellingerhout D, Conrad CA, Malloy C, Sherry AD, Lai SY, Hazle JD. Kinetic Modeling and Constrained Reconstruction of Hyperpolarized [1-13C]-Pyruvate Offers Improved Metabolic Imaging of Tumors. Cancer Res 75(22):4708-4717, 2015. e-Pub 2015. PMID: 26420214.
Kim JY, Ryu JH, Schellingerhout D, Sun IC, Lee SK, Jeon S, Kim J, Kwon IC, Nahrendorf M, Ahn CH, Kim K, Kim DE. Direct Imaging of Cerebral Thromboemboli Using Computed Tomography and Fibrin-targeted Gold Nanoparticles. Theranostics 5(10):1098-1114, 2015. e-Pub 2015. PMID: 26199648.
Nute JL, Le Roux L, Chandler AG, Baladandayuthapani V, Schellingerhout D, Cody DD. Differentiation of low-attenuation intracranial hemorrhage and calcification using dual-energy computed tomography in a phantom system. Invest Radiol 50(1):9-16, 2015. e-Pub 2015. PMID: 25162534.
Ryu WS, Woo SH, Schellingerhout D, Chung MK, Kim CK, Jang MU, Park KJ, Hong KS, Jeong SW, Na JY, Cho KH, Kim JT, Kim BJ, Han MK, Lee J, Cha JK, Kim DH, Lee SJ, Ko Y, Cho YJ, Lee BC, Yu KH, Oh MS, Park JM, Kang K, Lee KB, Park TH, Lee J, Choi HK, Lee K, Bae HJ, Kim DE. Grading and interpretation of white matter hyperintensities using statistical maps. Stroke 45(12):3567-3575, 2014. e-Pub 2014. PMID: 25388424.
Le Roux LG, Bredow S, Grosshans D, Schellingerhout D. Molecular imaging detects impairment in the retrograde axonal transport mechanism after radiation induced spinal cord injury. Mol Imaging Biol 16(4):504-510, 2014. e-Pub 2014. PMID: 24395625.
Park JY, Lee SK, Kim JY, Je KH, Schellingerhout D, Kim DE. A new micro-computed tomography-based high-resolution blood-brain barrier imaging technique to study ischemic stroke. Stroke 45(8):2480-2484, 2014. e-Pub 2014. PMID: 25013021.
Ahmed S, Hamilton J, Colen R, Schellingerhout D, Vu T, Rao G, McAleer MF, Mahajan A. Change in postsurgical cavity size within the first 30 days correlates with extent of surrounding edema: consequences for postoperative radiosurgery. J Comput Assist Tomogr 38(3):457-460, 2014. e-Pub 2014. PMID: 24681852.
Raslan O, Debnam JM, Ketonen L, Kumar AJ, Schellingerhout D, Wang J. Stereoscopic visualization of diffusion tensor imaging data: a comparative survey of visualization techniques. Radiol Res Pract. e-Pub 2013. PMID: 24251037.
Shin IJ, Shon SM, Schellingerhout D, Park JY, Kim JY, Lee SK, Lee DK, Lee HW, Ahn BC, Kim K, Kwon IC, Kim DE. Characterization of partial ligation-induced carotid atherosclerosis model using dual-modality molecular imaging in ApoE knock-out mice. PLoS One 8(9):e73451, 2013. e-Pub 2013. PMID: 24069197.
Walker CM, Lee J, Ramirez MS, Schellingerhout D, Millward S, Bankson JA. A catalyzing phantom for reproducible dynamic conversion of hyperpolarized [1-13C]-pyruvate. PLoS One 8(8):e71274, 2013. e-Pub 2013. PMID: 23977006.
Noh SM, Choi WJ, Kang BT, Jeong SW, Lee DK, Schellingerhout D, Yeo JS, Kim DE. Complementarity between (18) F-FDG PET/CT and Ultrasonography or Angiography in Carotid Plaque Characterization. J Clin Neurol 9(3):176-185, 2013. e-Pub 2013. PMID: 23894241.
Shon SM, Choi Y, Kim JY, Lee DK, Park JY, Schellingerhout D, Kim DE. Photodynamic therapy using a protease-mediated theranostic agent Reduces cathepsin-B activity in mouse atheromata in vivo. Arterioscler Thromb Vasc Biol 33(6):1360-1365, 2013. e-Pub 2013. PMID: 23539220.
Shawa H, Busaidy NL, Schellingerhout D, Habra MA. Unilateral renal artery stenosis with renal atrophy in a patient with metastatic papillary thyroid carcinoma treated with sorafenib. BMJ Case Rep. e-Pub 2013. PMID: 23682094.
Kim DE, Kim JY, Sun IC, Schellingerhout D, Lee SK, Ahn CH, Kwon IC, Kim K. Hyperacute direct thrombus imaging using computed tomography and gold nanoparticles. Ann Neurol 73(5):617-625, 2013. e-Pub 2013. PMID: 23495101.
Hunter GJ, Schellingerhout D, Vu TH, Perrier ND, Hamberg LM. Accuracy of four-dimensional CT for the localization of abnormal parathyroid glands in patients with primary hyperparathyroidism. Radiology 264(3):789-795, 2012. e-Pub 2012. PMID: 22798226.
Schellingerhout D, LeRoux LG, Hobbs BP, Bredow S. Impairment of retrograde neuronal transport in oxaliplatin-induced neuropathy demonstrated by molecular imaging. PLoS One 7(9):e45776, 2012. e-Pub 2012. PMID: 23029238.
Kim DE, Kim JY, Nahrendorf M, Lee SK, Ryu JH, Kim K, Kwon IC, Schellingerhout D. Direct thrombus imaging as a means to control the variability of mouse embolic infarct models: the role of optical molecular imaging. Stroke 42(12):3566-3573, 2011. e-Pub 2011. PMID: 22020025.
Kim JY, Park JH, Jeong SW, Schellingerhout D, Park JE, Lee DK, Choi WJ, Chae SL, Kim DE. High levels of remnant lipoprotein cholesterol is a risk factor for large artery atherosclerotic stroke. J Clin Neurol 7(4):203-209, 2011. e-Pub 2011. PMID: 22259616.
Lee DK, Choi Y, Shon SM, Schellingerhout D, Park JE, Kim DE. Atorvastatin and clopidogrel interfere with photosensitization in vitro. Photochem Photobiol Sci 10(10):1587-1592, 2011. e-Pub 2011. PMID: 21748161.
Vu TH, Guha-Thakurta N, Harrell RK, Ahmed S, Kumar AJ, Johnson VE, Perrier ND, Hamberg LM, Hunter GJ, Schellingerhout D. Imaging characteristics of hyperfunctioning parathyroid adenomas using multiphase multidectector computed tomography: a quantitative and qualitative approach. J Comput Assist Tomogr 35(5):560-567, 2011. e-Pub 2011. PMID: 21926850.
Shah KB, Guha-Thakurta N, Schellingerhout D, Madewell JE, Kumar AJ, Costelloe CM. Comparison of gadolinium-enhanced fat- saturated T1-weighted FLAIR and fast spin-echo MRI of the spine at 3 T for evaluation of extradural lesions. AJR Am J Roentgenol 197(3):697-703, 2011. e-Pub 2011. PMID: 21862814.
Wu J, Langford LA, Schellingerhout D, Guha-Thakurta N, Tummala S, Weinberg JS, Puduvalli VK. Progressive multifocal leukoencephalopathy in a patient with glioblastoma. J Neurooncol 103(3):791-796, 2011. e-Pub 2011. PMID: 21120583.
Shon SM, Park JH, Nahrendorf M, Schellingerhout D, Kim JY, Kang BT, Jeong SW, Kim EJ, Ryu JH, Kim K, Kwon IC, Lee DK, Lee MM, Kim DE. Exercise attenuates matrix metalloproteinase activity in preexisting atherosclerotic plaque. Atherosclerosis 216(1):67-73, 2011. e-Pub 2011. PMID: 21334624.
Ong SS, Bruner J, Schellingerhout D, Puduvalli VK. Papillary endothelial hyperplasia presenting as recurrent malignant glioma. J Neurooncol 102(3):491-498, 2011. e-Pub 2011. PMID: 20740304.
Raslan OA, Schellingerhout D, Fuller GN, Ketonen LM. Rosai-Dorfman disease in neuroradiology: imaging findings in a series of 10 patients. AJR Am J Roentgenol 196(2):W187-193, 2011. e-Pub 2011. PMID: 21257861.
Kim DE, Park KJ, Schellingerhout D, Jeong SW, Ji MG, Choi WJ, Tak YO, Kwan GH, Koh EA, Noh SM, Jang HY, Kim TY, Jeong JW, Lee JS, Choi HK. A new image-based stroke registry containing quantitative magnetic resonance imaging data. Cerebrovasc Dis 32(6):567-576, 2011. e-Pub 2011. PMID: 22104691.
Kim DE, Kim JY, Schellingerhout D, Kim EJ, Kim HK, Lee S, Kim K, Kwon IC, Shon SM, Jeong SW, Im SH, Lee DK, Lee MM, Kim GE. Protease imaging of human atheromata captures molecular information of atherosclerosis, complementing anatomic imaging. Arterioscler Thromb Vasc Biol 30(3):449-456, 2010. e-Pub 2010. PMID: 20056915.
Muzzafar S, Ketonen L, Weinberg JS, Schellingerhout D. Imaging and clinical features of an intra-axial brain stem schwannoma. AJNR Am J Neuroradiol 31(3):567-569, 2010. e-Pub 2010. PMID: 19833800.
Schellingerhout D, Le Roux LG, Bredow S, Gelovani JG. Fluorescence imaging of fast retrograde axonal transport in living animals. Mol Imaging 8(6):319-329, 2009. e-Pub 2009. PMID: 20003890.
Kim DE, Kim JY, Schellingerhout D, Shon SM, Jeong SW, Kim EJ, Kim WK. Molecular imaging of cathepsin B proteolytic enzyme activity reflects the inflammatory component of atherosclerotic pathology and can quantitatively demonstrate the antiatherosclerotic therapeutic effects of atorvastatin and glucosamine. Mol Imaging 8(5):291-301, 2009. e-Pub 2009. PMID: 19796606.
Debnam JM, Schellingerhout D, Kumar AJ, Ketonen L, Shah K, Hamberg LM, Hunter GJ. Multidetector CT-guided lumbar puncture in patients with cancer. Interv Neuroradiol 15(1):61-66, 2009. e-Pub 2009. PMID: 20465930.
Debnam JM, Schellingerhout D. Focal cement accumulation in lytic metastatic lesions: a new sign in vertebroplasty?. Interv Neuroradiol 14(4):465-470, 2008. e-Pub 2008. PMID: 20557749.
Le Roux LG, Volgin A, Maxwell D, Ishihara K, Gelovani J, Schellingerhout D. Optimizing imaging of three-dimensional multicellular tumor spheroids with fluorescent reporter proteins using confocal microscopy. Mol Imaging 7(5):214-221, 2008. e-Pub 2008. PMID: 19123991.
Mortenson MM, Evans DB, Lee JE, Hunter GJ, Schellingerhout D, Vu T, Edeiken BS, Feng L, Perrier ND. Parathyroid exploration in the reoperative neck: improved preoperative localization with 4D-computed tomography. J Am Coll Surg 206(5):888-896, 2008. e-Pub 2008. PMID: 18471717.
Rodgers SE, Hunter GJ, Hamberg LM, Schellingerhout D, Doherty DB, Ayers GD, Shapiro SE, Edeiken BS, Truong MT, Evans DB, Lee JE, Perrier ND. Improved preoperative planning for directed parathyroidectomy with 4-dimensional computed tomography. Surgery 140(6):932-940; discussion 940-941, 2006. e-Pub 2006. PMID: 17188140.
Kim DE, Tsuji K, Kim YR, Mueller FJ, Eom HS, Snyder EY, Lo EH, Weissleder R, Schellingerhout D. Neural stem cell transplant survival in brains of mice: assessing the effect of immunity and ischemia by using real-time bioluminescent imaging. Radiology 241(3):822-830, 2006. e-Pub 2006. PMID: 17114629.
Rogers LR, Rock JP, Sills AK, Vogelbaum MA, Suh JH, Ellis TL, Stieber VW, Asher AL, Fraser RW, Billingsley JS, Lewis P, Schellingerhout D, Shaw EG, Shaw EG. Results of a phase II trial of the GliaSite radiation therapy system for the treatment of newly diagnosed, resected single brain metastases. J Neurosurg 105(3):375-384, 2006. e-Pub 2006. PMID: 16961129.
Mullins ME, Lev MH, Schellingerhout D, Gonzalez RG, Schaefer PW. Intracranial hemorrhage complicating acute stroke: how common is hemorrhagic stroke on initial head CT scan and how often is initial clinical diagnosis of acute stroke eventually confirmed?. AJNR Am J Neuroradiol 26(9):2207-2212, 2005. e-Pub 2005. PMID: 16219823.
Kim DE, Schellingerhout D, Jaffer FA, Weissleder R, Tung CH. Near-infrared fluorescent imaging of cerebral thrombi and blood-brain barrier disruption in a mouse model of cerebral venous sinus thrombosis. J Cereb Blood Flow Metab 25(2):226-233, 2005. e-Pub 2005. PMID: 15678125.
Kim DE, Schellingerhout D, Ishii K, Shah K, Weissleder R. Imaging of stem cell recruitment to ischemic infarcts in a murine model. Stroke 35(4):952-957, 2004. e-Pub 2004. PMID: 14988578.
Tung CH, Zeng Q, Shah K, Kim DE, Schellingerhout D, Weissleder R. In vivo imaging of beta-galactosidase activity using far red fluorescent switch. Cancer Res 64(5):1579-1583, 2004. e-Pub 2004. PMID: 14996712.
Schellingerhout D, Lev MH, Bagga RJ, Rincon S, Berdichevsky D, Thangaraj V, Gonzalez RG, Alpert NM. Coregistration of head CT comparison studies: assessment of clinical utility. Acad Radiol 10(3):242-248, 2003. e-Pub 2003. PMID: 12643550.
Schellingerhout D, Accorsi R, Mahmood U, Idoine J, Lanza RC, Weissleder R. Coded aperture nuclear scintigraphy: a novel small animal imaging technique. Mol Imaging 1(4):344-353, 2002. e-Pub 2002. PMID: 12926230.
Chew FS, Schellingerhout D, Keel SB. Primary lymphoma of skeletal muscle. AJR Am J Roentgenol 172(5):1370, 1999. e-Pub 1999. PMID: 10227519.
Chew FS, Schellingerhout D, Keel SB. Late tracheal compression complicating plombage. AJR Am J Roentgenol 172(2):372, 1999. e-Pub 1999. PMID: 9930785.
Schellingerhout D, Jr BA, Marecos E, Spear M, Breakefield X, Weissleder R. Mapping the in vivo distribution of herpes simplex virions. Hum Gene Ther 9(11):1543-1549, 1998. e-Pub 1998. PMID: 9694153.

Invited Articles

Najjar AM, Johnson JM, Schellingerhout D. The Emerging role of Amino Acid PET in Neuro-Oncology. Bioengineering (Basel) 5(4), 2018. e-Pub 2018. PMID: 30487391.
Le Roux LG, Schellingerhout D. Molecular neuroimaging: the basics. Seminars in Roentgenol 49(2):225-233, 2014. e-Pub 2014. PMID: 24836496.
Debnam JM, Schellingerhout D. Diffusion MR Imaging of the Brain in Patients with Cancer. Int J Mol Imaging 2011:714021, 2011. e-Pub 2011. PMID: 22121483.
Lee DK, Nahrendorf M, Schellingerhout D, Kim DE. Will molecular optical imaging have clinically important roles in stroke management, and how?. J Clin Neurol 6(1):10-18, 2010. e-Pub 2010. PMID: 20386638.
Schellingerhout D, Gelovani J. Clinical trials in a molecular world. Neuroimaging Clin N Am 16(4):681-694, 2006. e-Pub 2006. PMID: 17148026.
Schellingerhout D. Molecular imaging of novel cell- and viral-based therapies. Neuroimaging Clin N Am 16(4):655-679, 2006. e-Pub 2006. PMID: 17148025.
Schellingerhout D, Josephson L. Molecular imaging of cell-based therapies. Neuroimaging Clin N Am 14(2):331-342, 2004. e-Pub 2004. PMID: 15182822.
Schellingerhout D, Jr BA. Viral imaging in gene therapy noninvasive demonstration of gene delivery and expression. Neuroimaging Clin N Am 12(4):571-581, 2002. e-Pub 2002. PMID: 12687912.

Abstracts

Sahin O, Wahid KA, Taku N, He R, Naser MA, R Mohamed AS, Amit M, Chen MM, Chronowski GM, Diaz Jr EM, Garden AS, Goepfert RP, Guenette JP, Gunn G, Hirvonen J, Hoebers F, Guha-Thakurta N, Jaskari J, Johnson J, Kann BH, Kaski K, Kaya D, Khanpara SD, Kristofer N, Lai SY, Lango M, Learned KO, Lee A, Lewis CM, Mäkitie A, Maniakas A, Moreno AC, Myers JN, Phan J, Pytynia KB, Rosenthal DI, Sahlsten J, Sandulache V, Schellingerhout D, Shah SJ, Sikora AG, Wintermark M, Fuller CD. Multi-Specialty Expert Physician Identification of Extranodal Extension in Oropharyngeal Computed Tomography Scans: Prospective Blinded Human Inter-Observer Performance Evaluation. e-Pub 2025.
D|| S. Using a Machine Learning Algorithm as a Prognostic in Glioma Patients. ASFNR Artificial Intelligence Workshop, 2022. e-Pub 2022.
Huichalaf CH, Goodwani SG, McReynolds MM, Hu CH, Actor P, Buggia-Prevot V, Ray WJ, Schellingerhout D, Le Roux L. Exploring In Vivo Neural Imaging as a Readout for HDAC6 Rescue of Axonal Transport after Oxaliplatin-Induced Peripheral Neuropathy. Peripheral Nerve society. Virtual, 2021. e-Pub 2021.
Le Roux LG, Qiu X, Jacobsen M, Piwnica-Worms D, Schellingerhout D. In Vivo Neural Imaging: The Impact of Retinal Neuropathy on Axonal Transport. Abstract # 3546796. The Association for Research in Vision and Ophthalmology (ARVO), 2021. e-Pub 2021.
Huichalaf CH, Goodwani SG, McReynolds MM, Hu CH, Actor P, Buggia-Prevot V, Ray WJ, Schellingerhout D, Le Roux L. Exploring In Vivo Neural Imaging as a Readout for Histone Deacetylase 6 Inhibitor Rescue of Axonal Transport after Oxaliplatin-Induced Peripheral Neuropathy. Abstract ID: GA451. Virtual World Molecular Imaging Conference, 2020. e-Pub 2020.
Gates E, Suki D, Weinberg J, Fuentes D, Schellingerhout D. Prognostic Value of Imaging-Based Estimates of Glioma Pathology Pre- and Post-Surgery. E-poster. Joint AAPM/COMP annual meeting, virtual, 2020. e-Pub 2020.
Gates E, Suki D, Weinberg J, Fuentes D, Schellingerhout D. Prognostic Value of Imaging-Based Estimates of Glioma Pathology Pre- and Post-Surgery, Plenary talk. NLM national trainee conference, virtual, 2020. e-Pub 2020.
Huichalaf CH, Goodwani SG, McReynolds MM, Hu CH, Actor P, Buggia-Prevot V, Ray WJ, Schellingerhout D, Le Roux L. Next Generation Pain Therapeutics: From Discovery to the Clinic. Gulf Coast Consortium (canceled due to Covid), 2020. e-Pub 2020.
Gates, E, Weinberg, J, Lin S, Prabhu S, Hamilton, Hazle JD, Fuller GN, Baladandayuthapani V, Fuentes D, Schellingerhout D. Combination of MRI Sequences Predicts Cellular Density in Glioma. American Medical Informatics Association Virtual Summit, Houston, TX, 2020. e-Pub 2020.
Gates E, Lin J, Weinberg J, Prabhu S, Hamilton J, Fuller G, Baladandayuthapani V, fuentes D, Schellingerhout D. Magnetic Resonance Imaging Based Model for Grading Glioma. American Medical Informatics Association Annual Symposium, Washington DC, 2019. e-Pub 2019.
Gates EDH, Schellingerhout D, Fuentes D. Combination of Multicontrast MRI Estimates Local Glioma Malignancy. Society for Industrial and Applied Mathematics (SIAM) TX-LA section meeting, Dallas, TX, 2019. e-Pub 2019.
Le Roux L, Qiu X, Jacobsen M, Gammon S, Piwnica-Worms D, Schellingerhout. Axonal transport as a clinically translatable in vivo biomarker for neuropathy. 7th State of the Science Cancer Survivorship Research Symposium. MD Anderson Cancer Center, Houston, TX, 2019. e-Pub 2019.
Le Roux L, Qiu X, Jacobsen M, Pagel M, Piwnica-Worms D, Schellingerhout. Axonal Transport as a Clinically Translatable in Vivo Biomarker for Neuropathy. 2019 Cancer Survivorship Research Symposium, 2019. e-Pub 2019.
Le Roux L, Qiu X, Jacobsen M, Piwnica-Worms D, Schellingerhout. In Vivo Neural Imaging: The Impact of Retinal Neuropathy on Axonal Transport. . First Annual Gulf Coast Consortium, Translational Imaging Symposium, 2019. e-Pub 2019.
Huichalaf CH, Goodwani SG, McReynolds MM, Hu CH, Actor P, Buggia-Prevot V, Ray WJ, Schellingerhout D, Le Roux L. Exploring In Vivo Neural Imaging as a Readout for Histone Deacetylase 6 Inhibitor Rescue of Axonal Transport after Oxaliplatin-Induced Peripheral Neuropathy. Abstract ID: GA451. Virtual World Molecular Imaging Conference, 2019. e-Pub 2019.
Huichalaf CH, Goodwani SG, McReynolds MM, Hu CH, Actor P, Buggia-Prevot V, Ray WJ, Schellingerhout D, Le Roux L. Exploring in vivo neural imaging as a readout for histone deacetylase 6 inhibitor rescue of axonal transport after oxaliplatin-induced peripheral neuropathy. World Molecular Imaging Congress, Montréal, Canada, 2019. e-Pub 2019.
Le Roux L, Qiu X, Jacobsen M, Piwnica-Worms D, Schellingerhout D. In Vivo Neural Imaging: |The Impact of Retinal Neuropathy on Axonal Transport. World Molecular Imaging Congress, Montréal, Canada, 2019. e-Pub 2019.
Le Roux L, Datar V, Jason H, Schott NJ, Armol G, David G, Schellingerhout D. Neurographic Imaging of Radiation Induced Spinal Cord Injury. World Molecular Imaging Congress, Montréal, Canada, 2019. e-Pub 2019.
Gates E, Lin J, Weinberg J, Fuentes D, Schellingerhout. Guiding the First Biopsy in Glioma Patients Using Estimated Ki-67 Maps Derived from MRI. National Library of Medicine Training Conference, Indianapolis IN, 2019. e-Pub 2019.
Le Roux L, Datar V, Jason H, Schott NJ, Armol G, David G, Schellingerhout D. Neurographic Imaging of Radiation Induced Spinal Cord Injury. Cancer Systems Imaging Annual Retreat, The University of Texas at MD Anderson Cancer Center, Cancer Systems Imaging, Galveston, TX, 2019. e-Pub 2019.
Datar V, Le Roux L, Huse J, Niedzielski JS, Ghia A, Grosshans D, Schellingerhout D. Neurographic Imaging of Radiation Induced Spinal Cord Injury. Cancer Systems Imaging Spring Scientific Symposium/Retreat, 2019. e-Pub 2019.
Le Roux L, Qiu X, Jacobsen M, Datar V, Piwnica-Worms D, Schellingerhout D. In Vivo Neural Imaging: The Impact of Retinal Neuropathy on Axonal Transport. Cancer Systems Imaging Annual Retreat, The University of Texas at MD Anderson Cancer Center, Cancer Systems Imaging, Galveston, TX, 2019. e-Pub 2019.
Gates E, Lin J, Weinberg J, Hamilton J, Prabhu S, Hazle J, Fuller G, Baladandayuthapani V, Fuentes D, Schellingerhout D. Estimated Maps of Proliferative Activity Present Alternative Targets For Initial Glioma Biopsy. 7th Intraoperative Imaging Society Meeting, Houston TX, 2019. e-Pub 2019.
Jacobsen MC, Cressman E, Duan X, Cody D, Schellingerhout D, Layman R. Limits for Detecting Low Concentrations of Iodine with Dual Energy Computed Tomography. Oral Presentation at the Radiological Society of North America Annual Meeting Chicago, IL, 2018. e-Pub 2018.
Le Roux LG, Qui X, Jacobsen M, Datar V, Schellingerhout D. Preserving Genital Nerves Function in Prostate Cancer: Imaging guidance with a Molecular Nerve Imaging Agent. World Molecular Imaging Congress, Seattle, Washington, 2018. e-Pub 2018.
Le Roux LG, Qui X, Jacobsen M, Datar V, Piwnica-Worms D, Schellingerhout D. Retinography as a model for Studying Chemotherapy – Induced Neuropathy. World Molecular Imaging Congress, Seattle, Washington, 2018. e-Pub 2018.
Pauloski JG, Zhang Z, Gates E, Schellingerhout D, Hazle JD, Fuentes D. Optimizing Deep Learning Methods for Image Segmentation with Distributed Training. Texas Advanced Computing Center Symposium for Texas Researchers, 2018. e-Pub 2018.
Gate E, Lin J, Weinberg J, Hamilton J, Prabhu S, Hazle J, Fuller G, Baladandayuthapani V, Fuentes D, Schellingerhout D. Quantitative Prediciton of Cellular Proliferation Marker Ki67 Using MR Imaging in Glioma. 60th Annual meeting of the American Association of Physicists in Medicine, 2018. e-Pub 2018.
Jacobsen MC, Cressman E, Duan X, Cody D, Schellingerhout D, Layman R. Detecting Iodine Enhancement with Dual-Energy Computed Tomography: How Low Can We Go?. Oral Presentation at the American Association of Physicists in Medicine Annual Meeting; 2018. Nashville, TN, 2018. e-Pub 2018.
Jacobsen MC, Duan X, Cody D, Cressman E, Schellingerhout D, Laymann RR. Determination of the limit of detection for iodinated contrast agents with Multi-Energy Computed Tomography. SPIE Medical Imaging; Houston, Texas, 2018. e-Pub 2018.
Lin JS, Fuentes D, McCutcheon I, Ferguson S, Prabhu S, Weinburg J, Fuller GN, Hazle JD, Schellingerhout D. Development of a Prediction Technique for Tissue Features using Radiological-Pathological Correlations. The University of Texas MD Anderson Cancer Center Diagnostic Imaging Trainee Research Symposium, 2016. e-Pub 2016.
Le Roux LG, Qui X, Ramos D, Flores LG, Piwnica-Worms D, Schellingerhout D. Retinography as a Model for Studying Chemotherapy-Induced Neuropathy: Proof of Concept in an Induced Glaucoma Model. Fourth State of the Science Cancer Survivorship Research Symposium, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2016. e-Pub 2016.
Le Roux LG, Vichaya EG, Flores LG, Ramos D, Schellingerhout D. Prevention of Oxaliplatin-Induced Neuropathy by using Minocycline as a Chemoprotectant: Demonstration by Imaging and Behavioral Assessment. Fourth State of the Science Cancer Survivorship Research Symposium, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2016. e-Pub 2016.
Le Roux LG, Ramos D, Flores LG, Schellingerhout D. Preserving Genital Nerve Function in Prostate Cancer: Imaging with a Molecular Imaging Agent. Fourth State of the Science Cancer Survivorship Research Symposium. The University of Texas MD Anderson Cancer Center, Houston, Texas, 2016. e-Pub 2016.
Le Roux LG, Vichaya EG, Flores LG, Ramos D, Schellingerhout D. Prevention of Oxaliplatin-Induced Neuropathy by using Minocycline as a Chemoprotectant: Demonstration by Imaging and Behavioral Assessment. Conference on Diagnosis, Mechanisms and Management of Cancer Treatment-Induced Neurotoxicities, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2016. e-Pub 2016.
Schellingerhout D, Flores L, Gomez D, Le Roux LG. Diabetic Neuropathy Can Be Demonstrated by Molecular Neurographic Imaging and Parallels Neurologic/Behavioral Findings. American Society of Neuroradiology 52nd Annual Meeting. Monteal, Canada. (poster), 2014. e-Pub 2014.
Garg N, Vining D, Schellingerhout D, Szklaruk J, Raval B, McEnery KW. Intelligent hanging protocols using control flow and regular expressions. Radiological Society of North America 97th Scientific Assembly and Annual Meeting, 2011. e-Pub 2011.
Schellingerhout D, Le Roux LG, Bredow S. Imaging retrograde neural transport with a molecular probe: neurography. American Society of Neuroradiology Annual Meeting:91, 2011. e-Pub 2011.
Le Roux LG, Schellingerhout D, Volgin A, Maxwell D, Ishihara K, Gelovani J. Optimizing imaging of 3D multicellular tumor spheroids with fluorescent reporter proteins using confocal micoscopy. 66th Annual Meeting of the Microscopy Society of America. (poster) 14(2):737-735, 2008. e-Pub 2008.
Raslan O, Schellingerhout D, Ketonen L, Debnam M, Kumar A, Wang J. Stereoscopic visualization of diffusion tensor imaging data. American Association of Physicists in Medicine Annual Meeting 35(6):241, 2008. e-Pub 2008.
Dagher SA, Gates EDH, Wintermark M, Long JP, Fuentes DT, Schellingerhout D. The prognostic value of parametrized Ki-67 maps derived from conventional MRI and machine learning in a large retrospective cohort of adult-type diffuse gliomas.
Dagher SA, Gates EDH, Wintermark M, Long JP, Fuentes DT, Schellingerhout D. The Prognostic Ability of the Ki-67 Proliferation Index Derived from Conventional MRI Sequences and Machine Learning in a Retrospective Cohort of 1179 Gliomas.
Dagher SA, Gates EDH, Wintermark M, Fuentes DT, Schellingerhout D. The Prognostic Significance of Contrast-Enhanced T1 Signal Intensity in a Large Retrospective Cohort of Adult-Type Diffuse Gliomas.

Book Chapters

Johnson JM, Gule-Monroe MK, Kwon M, Ahmed S, Schellingerhout D, Kumar VA, Edeiken-Monro BS, Debnam JM. Pattern Recognition of Benign and Malignant Thyroid Nodules: Ultrasound Characteristics and Ultrasound-Guided Fine Needle Aspiration of Thyroid Nodules. In: Advanced Thyroid and Parathyroid Ultrasound. Springer International Publishing, 179-194, 2017.
Raslan O, Ketonen L, Fuller G, Schellingerhout D. Central Nervous System Rosai-Dorfman Disease. In: "Methods of Cancer Diagnosis, Therapy and Prognosis.". 1. Springer Company, 392, 2011.
Kundra V, Schellingerhout, Jackson EF. Targeted and Functional Imaging. In: Targeted Cancer Therapy. Kurzrock R, Markman M. Humana Press, 335-361, 2008.
Weissleder R, Schellingerhout D. Newer MR Contrast Agents. In: "Radiology: Diagnosis-Imaging-Intervention.". 3. Lippincott-Raven, 1-12, 1997.

Less

Selected Presentations & Talks

Local Presentations

2024. The prognostic value of parametrized Ki-67 maps derived from conventional MRI and machine learning in a large retrospective cohort of adult-type diffuse gliomas. Conference. MD Anderson Diagnostic Imaging Trainee Research Symposium. Houston, TX, US.
2021. The Calcium vs Hemorrhage Trial. Conference. M D Anderson Cancer Center. Houston, TX, US.
2020. Imaging-Pathologic correlations: Results from the Stereotactic RadPath Trial. Conference. M.D Anderson Cancer Center. Houston, TX, US.
2019. Axonal transport as a clinically translatable in vivo biomarker for neuropathy. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2018. The Stereotactic RadPath Trial: Interim Results. Conference. Neuroradiology Fellow Training Lecture. Houston, TX, US.
2018. Introduction to Head and Neck Imaging. Conference. The Graduate School of Biomedical Sciences (GS02 1083) Clinical Imaging Course, The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2018. Imaging Anatomy: Brain MR. Conference. The Graduate School of Biomedical Physics Students Class, The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2018. The Stereotactic RadPath Trial: interim results. Conference. Brain Tumor Center Research Retreat. Houston, TX, US.
2017. Molecular Neuroimaging. Conference. Neuroscience Update in Pediatric Neuro-oncology. Houston, TX, US.
2017. Imaging-Pathologic-Genomic Correlations in Glioma Patients: the Stereotactic RadPath Trial. Conference. Gulf Coast Consortium Radiomics Conference. Houston, TX, US.
2017. Preserving Genital Nerve Function in Prostate Cancer: Imaging with a Molecular Imaging Agent. Conference. Fifth State of the Science Cancer Survivorship Research Symposium, MD Anderson Cancer Center. Houston, TX, US.
2016. Fast-Switching Dual-Energy Computed Tomography for Classification of Intracranial Hemorrhage and Calcification: Preliminary Results of a Human Trial. Conference. The University of Texas MD Anderson Cancer Center, Division of Diagnostic Imaging Trainee Research Day. Houston, TX, US.
2015. MR of the Brain. Conference. The University of MD Anderson Cancer Center. Houston, TX, US.
2015. Update on the Stereotactic RadPath Clinical Trial. Conference. The University of Texas MD Anderson Cancer Center, Department of Cancer Systems Imaging. Houston, TX, US.
2011. Neurography: Using Molecular Imaging to Demonstrate Oxaliplatin-induced Neuropathy. Conference. The University of Texas MD Anderson Cancer Center CABIR Retreat. Houston, TX, US.
2009. Visualizing Stem Cell Chemotaxis with Molecular Imaging. Conference. The University of Texas MD Anderson Cancer Center Brain Tumor Research Retreat. Houston, TX, US.
2008. Minimally Invasive Vertebral Augmentation for Metastatic Spine Fractures: General Introduction and Invitation to Participate in an Upcoming Clinical Trial. Conference. The University of Texas MD Anderson Cancer Center Genitourinary Oncology Group. Houston, TX, US.
2008. Minimally Invasive Vertebral Augmentation for Metastatic Spine Fractures: General Introduction and Invitation to Participate in an Upcoming Clinical Trial. Conference. The University of Texas MD Anderson Cancer Center Breast Oncology Group. Houston, TX, US.
2008. A Molecular Imaging Agent for Neurography. Conference. The University of Texas MD Anderson Cancer Center Technology Commercialization Presentation. Houston, TX, US.
2008. Cavity SpineWand Tutorial. Conference. Arthrocare. Houston, TX, US.
2008. The Cavity SpineWand Trial. Conference. The University of Texas MD Anderson Cancer Center Interventional Radiology Research Seminar. Houston, TX, US.
2008. Molecular Neuroimaging and Radiology Research Trials and Projects. Conference. The University of Texas MD Anderson Cancer Center Head and Neck Surgery Research Seminar. Houston, TX, US.
2007. Minimally Invasive Therapies for Vertebral Fractures. Conference. The University of Texas MD Anderson Cancer Center Diagnostic Imaging Week Seminar. Houston, TX, US.
2007. Development of a Molecular Imaging Tracer for Neurography. Conference. The University of Texas MD Anderson Cancer Center Institutional Grand Rounds. Houston, TX, US.
2007. High-energy gamma ray imaging on a conventional gamma camera using coded apertures. Conference. Houston Society for Engineering in medicine and Biology 24th Annual Conference on Biomedical Engineering Research. Houston, TX, US.
2006. Enhanced Vertebroplasty for Vertebral Compression Fractures Caused by Metastatic Tumors. Conference. Webcast organized by Arthrocare. Houston, TX, US.
2006. Minimally Invasive Spine Procedures: Vertebroplasty and Kyphoplasty. Conference. The University of Texas MD Anderson Cancer Center Breast Carcinoma Teaching Conference. Houston, TX, US.
2006. Minimally Invasive Therapies for Vertebral Fractures: Vertebroplasty and Kyphoplasty. Conference. American Radiological Nurses Association, Texas Gulf Coast Chapter. Houston, TX, US.
2005. Molecular Neuroimaging. Conference. The University of Texas MD Anderson Cancer Center Brain Tumor Center Information Exchange Series. Houston, TX, US.
2005. Molecular Neuroimaging. Conference. Research Imaging Seminar. Houston, TX, US.
2005. Coded Aperture Imaging: A Novel Technology for High Resolution Nuclear Imaging. Conference. The University of Texas MD Anderson Cancer Center Brain Tumor Center. Houston, TX, US.
2004. Molecular Neuroimaging. Conference. The University of Texas MD Anderson Cancer Center Brain Tumor Center Research Retreat. Houston, TX, US.

Regional Presentations

2024. The Prognostic Significance of Contrast-Enhanced T1 Signal Intensity in a Large Retrospective Cohort of Adult-Type Diffuse Gliomas. Conference. ASNR Annual Meeting. Las Vegas, NV, US.
2023. Ultrasound Anatomy of the Neck. Conference. MD Anderson Cancer Center, US.
2017. Fast-Switching Dual-Energy Computed Tomography for Classification of Intracranial Hemorrhage and Calcification: Preliminary Results of a Human Trial. Conference. The University of Texas MD Anderson Cancer Center, Division of Diagnostic Imaging Trainee Research Day. Montgomery, TX, US.
2016. Molecular Imaging of Neural Transport. Conference. The University of MD Anderson Cancer Systems Imaging Retreat. Galveston, TX, US.
2016. Differentiation of Calcium- and Iron-Based Lesions using Phase-Sensitive MRI: Initial Results in a Phantom System. Conference. The University of Texas MD Anderson Cancer Center, Department of Cancer Systems Imaging Annual Retreat. Galveston, TX, US.
2015. Differentiation and Identification of Intracranial Hemorrhage and Calcification using Dual-energy Computed Tomography in a Phantom System. Conference. Poster presentation at: University of Texas MD Anderson Cancer Center Department of Imaging Physics Annual Retreat. Cleveland, TX, US.
2015. Differentiation and Identification of Intracranial Hemorrhage and Calcification using Dual-energy Computed Tomography in a Phantom System. Conference. The University of Texas MD Anderson Cancer Center, Department of Cancer Systems Imaging Annual Retreat. New Braunfels, TX, US.
2007. Oncologic Spinal Interventions, the Interventionist's Perspective. Conference. Arthrocare Company Retreat. LaCosta, CA, US.
2004. Molecular Neuroimaging. Conference. Eastern Neuroradiological Society 16th Annual Meeting. Boston, MA, US.
2003. Molecular Imaging in Neuroradiology. Conference. Eastern Neuroradiological Society 15th Annual Meeting. Colonial Williamsburg, VA, US.
2003. Coded Aperture Nuclear Imaging: Initial Experience in Biomedical Research. Conference. New England Chapter of the American Association of Physicists in Medicine. Plymouth, MA, US.

National Presentations

2024. The Prognostic Ability of the Ki-67 Proliferation Index Derived from Conventional MRI Sequences and Machine Learning in a Retrospective Cohort of 1179 Gliomas. Conference. Dagher SA (Presenter), Gates EDH, Wintermark M, Long JP, Fuentes DT, Schellingerhout D. Las Vegas, NV, US.
2022. Using a Machine Learning Algorithm as a Prognostic in Glioma Patients. Conference. 15th Annual Meeting American Society of Functional Neuroradiology. Maui, HI, US.
2021. Exploring In Vivo Neural Imaging as a Readout for HDAC6 Rescue of Axonal Transport after Oxaliplatin-Induced Peripheral Neuropathy. Conference. Peripheral Nerve society. Virtual, US.
2021. In Vivo Neural Imaging: The Impact of Retinal Neuropathy on Axonal Transport. Abstract # 3546796. Conference. The Association for Research in Vision and Ophthalmology (ARVO), US.
2021. Dual-Energy CT of the Brain, Head and Neck. Invited. American Roentgen Ray Society, Virtual Conference, US.
2019. Axonal transport as a clinically translatable in vivo biomarker for neuropathy. Conference. 7th State of the Science Cancer Survivorship Research Symposium. MD Anderson Cancer Center. Houston, TX, US.
2019. In Vivo Neural Imaging: The Impact of Retinal Neuropathy on Axonal Transport. Conference. First Annual Gulf Coast Consortium, Translational Imaging Symposium. Houston, TX, US.
2019. Neurographic Imaging of Radiation Induced Spinal Cord Injury. Conference. Cancer Systems Imaging Annual Retreat. Galveston, TX, US.
2018. Radiological-Pathological Correlations and Imaging Signatures for Gliomas. Conference. American Society of Neuroradiology 56th Annual Meeting. Vancouver, Canada, US.
2018. Quantitative Susceptibility Mapping of Intracranial Calcification and Hemorrhage: Preliminary Results from a Human Trial. Conference. American Society of Neuroradiology 56th Annual Meeting. Vancouver, Canada, US.
2018. Localization of Parathyroid adenomas by Tc99m Sestamibi SPECT-CT, 4DCT and combination of SPECT-CT and 4DCT. Conference. Proceedings of the American Society of Neuroradiology 56th Annual Meeting, US.
2018. Retinography Based on Fast Axonal Transport of TTc-488 in a Rodent Glaucoma Model. Conference. American Society of Neuroradiology 56th Annual Meeting. Vancouver, Canada, US.
2018. The Stereotactic RadPath Trial: Interim results. Invited. Clinical Imaging and Intervention Conference. Houston, TX, US.
2018. Determination of the limit of detection for iodinated contrast agents with Multi-Energy Computed Tomography. Conference. SPIE Medical Imaging. Houston, TX, US.
2017. Retinography as a model for studying chemotherapy – induced neuropathy: proof of concept in an induced glaucoma model. Conference. American Society of Neuroradiology 55th Annual Meeting. Long Beach, CA, US.
2016. Evaluation of delayed FDG-PET in differentiating progressive disease from pseudoprogression in brain tumors. Conference. Western Neuroradiological Society 48th Annual Meeting Program. Austin, TX, US.
2015. Retinography: Neurographic molecular imaging with a near infrared optical imaging probe to assess the function and number of retinal ganglion cells in glaucoma. Conference. AACR-SNMMI State-of-the-Art Molecular Imaging in Cancer Biology and Therapy Joint Conference. San Diego, CA, US.
2014. Differentiation of low-attenuation intracranial hemorrhage and calcification using dual-energy computed tomography in a phantom system. Conference. Radiological Society of North America Scientific Assembly and Annual Meeting. Chicago, IL, US.
2013. Predicting the Spread of Glial Tumors: Insights from the Posterior and Retrosplenial Cingulate Cortex (BA 23, 31, 26, 29, and 30). Conference. Radiological Society of North America Annual Meeting. Chicago, IL, US.
2013. Imaging appearance and spread pattern of glial tumors in the supplementary motor area (Brodman Area 6). Conference. Radiological Society of North America Annual Meeting. Chicago, IL, US.
2013. Localization of parathyroid adenomas by Tc99m sestamibi SPECT-CT, contrast-enhanced multi-phase CT (4D-CT) and combination of SPECT-CT and 4D-CT. Conference. Radiological Society of North America Annual Meeting. Chicago, IL, US.
2013. Neurographic imaging with a molecular probe. Conference. American Society of Neuroradiology 51st Annual Meeting. San Diego, CA, US.
2013. Assessment of nonenhancing T2 signal abnormalities before or after treatment of brain tumors: Myoinositol and apparent diffusion coefficient values may be more helpful than choline ratios and perfusion. Conference. American Society of Neuroradiology 51st Annual Meeting. San Diego, CA, US.
2013. On the Shoulders of Giants: Elemental brain volumes derived from modifications of prior parcellation strategies help to explain glial tumor spread. Conference. American Society of Neuroradiology 51st Annual Meeting. San Diego, CA, US.
2013. Elemental brain volumes derived from cytoarchitectonics and crossing white matter tracts are an independent predictor of mortality for glioma with improved understanding of infiltration. Conference. American Society of Neuroradiology 51st Annual Meeting. San Diego, CA, US.
2013. Oxaliplatin-induced neuropathy can be demonstrated by imaging: Molecular neurography in a mouse model. Conference. American Society of Neuroradiology 51st Annual Meeting. San Diego, CA, US.
2013. Prevention of oxaliplatin-induced neuropathy by minocycline: Demonstration by imaging and behavioral assessment. Conference. American Society of Neuroradiology 51st Annual Meeting. San Diego, CA, US.
2013. Retrograde axonal transport is impaired after radiation injury: Demonstration with neurographic molecular imaging. Conference. American Society of Neuroradiology 51st Annual Meeting. San Diego, CA, US.
2013. Predicting recurrent glioma versus treatment-related necrosis using multiparameter advanced MR imaging: Accurate and cost-effective clinical decision-making. Conference. American Association of Neurosurgery Tumor Section. New Orleans, LA, US.
2012. Characterization of brain foci of susceptibility into hemorrhagic or calcific etiologies using gemstone spectral imaging-CT: Preliminary work in a phantom system. Conference. Radiological Society of North America Annual Meeting. Chicago, IL, US.
2012. Characterization of brain foci of susceptibility into hemorrhagic or calcific etiologies using gemstone spectral imaging-CT. Conference. American Association of Physicists in Medicine Annual Meeting. Charlotte, NC, US.
2012. Optimizing confocal imaging of neuronal transport in a microfluidic platform. Conference. Microscopy and Microanalysis Annual Meeting. Phoenix, AZ, US.
2012. Oxaliplatin-induced neuropathy can be demonstrated by molecular neurography: proof-of-principle in an animal model. Conference. American Society of Neuroradiology 50th Annual Meeting. New York, NY, US.
2012. Molecular imaging detects impairment in the retrograde axonal transport mechanism after radiation injury. Conference. American Society of Neuroradiology 50th Annual Meeting. New York, NY, US.
2012. Neurography: Imaging neural transport with a molecular probe. Conference. American Society of Neuroradiology 50th Annual Meeting. New York, NY, US.
2012. Characterization of brain foci of susceptibility into hemorrhagic or calcific etiologies using gemstone spectral imaging-CT. Conference. Southwest American Association of Physicists in Medicine. Oklahoma City, OK, US.
2011. Molecular Imaging for Central Nervous System Malignancies. Invited. Radiological Society of North America 97th Scientific Assembly and Annual Meeting. Chicago, IL, US.
2011. Intelligent hanging protocols using control flow and regular expressions. Conference. Radiological Society of North America 97th Scientific Assembly and Annual Meeting. Chicago, IL, US.
2011. Imaging retrograde neural transport with a molecular probe: neurography. Conference. American Society of Neuroradiology 49th Annual Meeting. Seattle, WA, US.
2011. Comparison of ultrasonography, Tc-99m sestmibi SPECT-CT and contrast CT in localization of parathyroid adenoma. Conference. Society for Nuclear Medicine Annual Meeting. San Antonio, TX, US.
2011. Neurography demonstrates that oxaliplatin chemotoxicity impairs retrograde axonal transport. Conference. American Society of Neuroradiology 49th Annual Meeting. Seattle, WA, US.
2010. Molecular Imaging for Central Nervous System Malignancies. Invited. Radiological Society of North America Annual Meeting. Chicago, IL, US.
2010. Molecular Imaging Advances in Oncology. Invited. Radiological Society of North America Annual Meeting. Chicago, IL, US.
2010. Primary hyperparathyroidism: comparison of 4D CT versus sestamibi-SPECT/CT for parathyroid adenoma localization. Conference. American Society for Head and Neck Radiology Annual Meeting. Houston, TX, US.
2010. Molecular imaging of retrograde neural transport. Conference. American Society of Neuroradiology Annual Meeting. Boston, MA, US.
2010. Experimental Diagnostic Imaging. Invited. National Student Research Forum. Galveston, TX, US.
2009. Diagnostic quality of contrast-enhanced T1 FLAIR vs contrast-enhanced T1 spin echo sagittal imaging in the spine at 3T. Conference. Radiological Society of North America 95th Scientific Assembly and Annual Meeting. Chicago, IL, US.
2009. Molecular Neuroimaging of Central Nervous System Malignancies. Invited. Radiological Society of North America Annual Meeting. Chicago, IL, US.
2009. Postoperative diffusion abnormalities in the follow-up of glioblastoma: final intra-operative MRI versus 24-hour postoperative study. Conference. Radiological Society of North America 95th Assembly and Annual Meeting. Chicago, IL, US.
2009. Primary Spinal Tumors: Role of Interventional Radiology. Invited. AOSpine North America Spine Tumor Symposium. Houston, TX, US.
2009. Primary Spinal Tumors: Imaging, MR and PET as Part of Staging. Invited. AOSpine North America Spine Tumor Symposium. Houston, TX, US.
2008. Molecular Neuroimaging. Invited. Radiological Society of North America Annual Meeting. Chicago, IL, US.
2008. A novel software algorithm for the quantitative assessment of fluorescent reporter proteins in multicellular tumor spheroids. Conference. Microscopy Society of America 66th Annual Meeting. Albuquerque, NM, US.
2008. Optimizing imaging of 3D multicellular tumor spheroids with fluorescent reporter proteins using confocal microscopy. Conference. 66th Annual Meeting of the Microscopy Society of America. Albuquerque, NM, US.
2008. Stereoscopic visualization of diffusion tensor imaging data: a comparative survey of several DTI visualization techniques. Conference. American Association of Physicists in Medicine. Houston, TX, US.
2008. Multiphasic, multidetector CT-enhancing characteristics of recurrent thyroid cancer. Conference. American Society of Neuroradiology Annual Meeting. New Orleans, LA, US.
2007. HIF-1alpha expression in tumor spheroids can be induced by either low glucose or hypoxia, and can be associated with increased tumor cell motility. Conference. Society for Molecular Imaging and Academy of Joint Molecular Imaging Conference. Providence, RI, US.
2007. Effectiveness of intraoperative magnetic resonance imaging for brain tumor resections: preliminary experience at MD Anderson Cancer Center. Conference. Congress of Neurological Surgeons. San Diego, CA, US.
2007. An optically labeled agent for the molecular imaging of retrograde neural transport. Conference. Society for Molecular Imaging and Academy of Joint Molecular Imaging Conference. Providence, RI, US.
2007. A software tool for analyzing confocal microscopy data in tumor spheroid models of hypoxia. Conference. Society for Molecular Imaging and Academy of Joint Molecular Imaging Conference. Providence, RI, US.
2007. Development of molecular imaging agents for the assessment of neural transport with scintigraphic and optical imaging modalities. Conference. American Society of Neuroradiology Annual Meeting. Chicago, IL, US.
2007. Early experience using a high-field strength intra-operative MRI system for neurosurgical guidance in tumor resection. Conference. American Society of Neuroradiology Annual Meeting. Chicago, IL, US.
2007. Trabecular versus focal distribution of polymethylmethacrylate cement in pathologic vertebral fractures during vertebroplasty of lytic metastasis: case series and correlation to outcomes. Conference. American Society of Neuroradiology Annual Meeting. Chicago, IL, US.
2007. Multidetector CT-guided lumbar puncture in cancer patients. Conference. American Society of Neuroradiology Annual Meeting. Chicago, IL, US.
2007. Early experience with intraoperative MRI (brain suite) tumor resections. Conference. Richard Lende Winter Neurosurgery Conference jointly sponsored by the American Association of Neurological Surgeons. Snowbird, UT, US.
2006. Development of agents for molecular imaging of neural transport with scintigraphic and optical imaging modalities. Conference. Society for Molecular Imaging 5th Annual Meeting. Big Island, HI, US.
2006. Molecular optical imaging of neural stem cell transplant survival influenced by host environments. Conference. Society for Molecular Imaging 5th Annual Meeting. Big Island, HI, US.
2006. Molecular imaging of tumor spheroids for screening of novel inhibitors of HIF1alpha signaling. Conference. Society for Molecular Imaging 5th Annual Meeting. Big Island, HI, US.
2006. A novel approach to quantitation of spatial and temporal dynamics of expression of fluorescent reporter proteins in multi-cellular tumor spheroids. Conference. Society for Molecular Imaging 5th Annual Meeting. Big Island, HI, US.
2006. Development and validation of a novel technology for production of multi-cellular tumor spheroids for high-contrast screening applications. Conference. Society for Molecular Imaging 5th Annual Meeting. Big Island, HI, US.
2006. Four-dimensional computed tomography: a novel imaging modality for localization of parathyroid tumors. Conference. Society of Surgical Oncology Annual Meeting. San Diego, CA, US.
2006. Four-dimensional computed tomography permits improved preoperative planning for directed parathyroidectomy. Conference. American Association of Endocrine Surgeons Annual Meeting. New York, NY, US.
2005. Rosai-Dorfman-Destombes disease in neuroradiology: imaging findings in six cases. Conference. Radiological Society of North America Annual Meeting. Chicago, IL, US.
2004. Molecular Neuroimaging. Invited. Radiological Society of North America. Chicago, IL, US.
2004. Molecular Imaging in Neuroradiology. Invited. American Society of Neuroradiology 42nd Annual Meeting. Seattle, WA, US.
2003. In vivo imaging of transplanted stem cell migration to ischemic stroke. Conference. American Society of Neuroradiology 41st Annual Meeting. Washington DC, US.
2003. Viral gene delivery to anatomically precise regions in the brain through precision high frequency focused ultrasound. Conference. American Society of Neuroradiology 41st Annual Meeting. Washington DC, US.
2003. Imaging of viral and non-viral gene delivery. Conference. Vector Targeting Strategies for Therapeutic Gene Delivery: Cold Spring Harbor Laboratory Biotechnology Conference. Cold Spring Harbor, NY, US.
2002. Viral gene delivery to anatomically precise regions in the brain through precision high-frequency focused ultrasound. Conference. Society for Molecular Imaging 1st Annual Meeting. Boston, MA, US.
2002. Coded aperture nuclear scintigraphy: a novel small animal imaging technique. Conference. Society for Molecular Imaging 1st Annual Meeting. Boston, MA, US.
2001. The use of imaging to assess viral delivery during gene therapy: how well does imaging predict distribution?. Conference. Radiological Society of North America Annual Meeting. Chicago, IL, US.
2001. A coded aperature for high-resolution nuclear medicine planar imaging with a conventional Anger camera: experimental results. Conference. Institute of Electrical and Electronics Engineers Nuclear Science Symposium and Medical Imaging Conference. San Diego, CA, US.
2001. High-resolution coded aperture planar scintigraphy of small animals. Conference. High Resolution Imaging in Small Animals: Instrumentation, Applications and Animal Handling Conference. Washington, DC, US.
2000. Accuracy of CT and MRI in stroke detection: does the availability of clinical history matter?. Conference. Radiological Society of North America Annual Meeting. Chicago, IL, US.
2000. Gene therapy to somatic organs: using imaging to assess pharmacological manipulations of viral mass distribution. Conference. Radiological Society of North America Annual Meeting. Chicago, IL, US.
2000. Acute stroke detection in a large emergency department series: accuracy of CT angiography (CTA). Conference. Radiological Society of North America Annual Meeting. Chicago, IL, US.
2000. Optimizing radiological projected images: balancing detail with storage constraints in digital age. Conference. Radiological Society of North America Annual Meeting. Chicago, IL, US.
2000. Delivery of viral gene therapy vectors to brain tumors - the effects of blood tumor barrier disruption using RMP-7 on herpes simplex virus mass distribution in a rat gliosarcoma model. Conference. American Society of Neuroradiology Annual Meeting. Atlanta, GA, US.
1999. The benefits of automated image co-registration in assessing interval change between initial and follow-up head CT scans. Conference. American Society of Neuroradiology Annual Meeting. Chicago, IL, US.
1998. Imaging gene therapy: tracking genetically engineered herpes simplex virus in vivo. Conference. Radiological Society of North America Annual Meeting. Chicago, IL, US.

International Presentations

2021. In Vivo Neural Imaging: The Impact of Retinal Neuropathy on Axonal Transport. Abstract # 3546796. Conference. The Association for Research in Vision and Ophthalmology (ARVO), US.
2020. Exploring In Vivo Neural Imaging as a Readout for Histone Deacetylase 6 Inhibitor Rescue of Axonal Transport after Oxaliplatin-Induced Peripheral Neuropathy. Abstract ID: GA451. Conference. Virtual World Molecular Imaging Conference, US.
2019. Autofluorescence Imaging in Stroke. Invited. Basic/Translational Stroke Research International Symposium Korean Stroke Society. Ilsan.
2019. In Vivo Neural Imaging: The Impact of Retinal Neuropathy on Axonal Transport (SS 141). Conference. World Molecular Imaging Congress. Montreal, CA.
2019. Neurographic Imaging of Radiation Induced Spinal Cord Injury (P246). Conference. World Molecular Imaging Congress. Montreal, CA.
2019. Exploring in vivo neural imaging as a readout for histone deacetylase 6 inhibitor rescue of axonal transport after oxaliplatin-induced peripheral neuropathy (P144). Conference. World Molecular Imaging Congress. Montreal, CA.
2017. Retinography: Nerve Transport in a Model of Glaucoma. Conference. World Molecular Imaging Congress. Philadelphia, US.
2017. Preserving Genital Nerve Function in Prostate Cancer. Conference. World Molecular Imaging Congress. Philadelphia, US.
2014. Neurographic imaging with a molecular probe. Conference. World Molecular Imaging Congress. Seoul.
2014. Prevention of oxaliplatin-induced neuropathy by minocycline: demonstration by imaging and behavioral assessment. Conference. World Molecular Imaging Congress. Seoul.
2014. A cell culture system to investigate the role of retrograde neuronal transport in chemotherapy-induced neuropathies. Conference. World Molecular Imaging Congress. Seoul.
2014. Retrograde axonal transport is impaired after radiation injury: demonstration with neurographic molecular imaging. Conference. World Molecular Imaging Congress. Seoul.
2014. Imaging Genital Nerves with a Molecular Imaging Agent: Preliminary Animal Studies. Conference. Annual American Society of Neuroradiology 52nd Meeting. Montreal, CA.
2014. Radiation Injury Can Be Detected with Neurographic Molecular Imaging. Conference. Annual American Society of Neuroradiology 52nd Meeting. Montreal, CA.
2014. Insights from the Ventral Premotor Cortex (BA 44): Glial Tumor Spread Pattern Important for Survival and Functional Outcomes. Conference. American Society of Neuroradiology 52nd Annual Meeting. Montreal, CA.
2014. Predicting the Spread of Glial Tumors: Insights from “Gliography” of the Cingulate. Conference. American Society of Neuroradiology 52nd Annual Meeting. Montreal, CA.
2014. Diabetic Neuropathy Can Be Demonstrated by Molecular Neurographic Imaging and Parallels Neurologic/Behavioral Findings. Conference. American Society of Neuroradiology 52nd Annual Meeting. Montreal, CA.
2014. Distinguishing Recurrent Thyroid Cancer from Normal Thyroid Tissue Using Multiphasic Multidetector Computed Tomography-Enhancing Characteristics. Conference. Annual American Society of Neuroradiology 52nd Meeting. Montreal, CA.
2014. Effects of ROI Measurement Technique on the Quantitative Assessment of Recurrent Thyroid Cancer During Multiphasic Multidetector CT. Conference. Annual American Society of Neuroradiology 52nd Meeting. Montreal, CA.
2014. Localization of Parathyroid Adenomas by Tc99m Sestamibi SPECT-CT, Contrast-Enhanced Multiphase Computed Tomography (4DCT) and Combination of SPECT-CT and 4DCT. Conference. Annual American Society of Neuroradiology 52nd Meeting. Montreal, CA.
2013. Prevention of oxaliplatin-induced neuropathy by minocycline: demonstration by imaging and behavioral assessment. Conference. World Molecular Imaging Congress Annual Congress. Savannah, US.
2013. Optimizing confocal imaging of neuronal transport in a microfluidic platform. Conference. World Molecular Imaging Congress Annual Congress. Savannah, US.
2013. Retrograde Axonal Transport is impaired after radiation injury: demonstration with neurographic molecular imaging. Conference. World Molecular Imaging Congress Annual Congress. Savannah, US.
2013. Neurographic imaging with a molecular probe. Conference. World Molecular Imaging Congress Annual Congress. Savannah, US.
2013. Predicting recurrent glioma versus treatment-related necrosis using multiparameter advanced MR imaging: Accurate and cost-effective clinical decision-making. Conference. American Association of Neurosurgery Tumor Section. New Orleans, US.
2012. Neurography: Imaging neural transport with a molecular imaging agent. Conference. World Molecular Imaging Congress Annual Congress. Dublin, IE.
2012. Optimizing confocal imaging of neuronal transport in a microfluidic platform. Conference. World Molecular Imaging Congress Annual Congress. Dublin, IE.
2012. Characterization of brain foci of susceptibility into hemorrhagic or calcific etiologies using gemstone spectral imaging-CT. Conference. American Association of Physicists in Medicine Annual Meeting. Charlotte, US.
2012. Characterization of calcium and iron solutions using Gemstone Spectral Imaging-CT to distinguish between hemorrhagic and calcific etiologies. Conference. European Congress of Radiology. Vienna, AT.
2012. Characterization of brain foci of susceptibility into hemorrhagic or calcific etiologies using gemstone spectral imaging-CT. Conference. Southwest American Association of Physicists in Medicine. Oklahoma City, US.
2011. Imaging retrograde neural transport with a molecular probe: neurography. Conference. World Molecular Imaging Congress Annual Congress. San Diego, US.
2011. Direct measurement of skin dose from CT Brain perfusion scans. Conference. 53rd Joint American Association of Physicists in Medicine/Canadian Organization of Medical Physicists Proceedings. Vancouver, CA.
2010. Photodynamic therapy as a tool of theranostics to detect and treat atherosclerotic plaques. Conference. World Molecular Imaging Congress Annual Congress. Kyoto, JP.
2010. Neurography shows a deleterious effect on retrograde axonal transport due to oxaliplatin therapy. Conference. World Molecular Imaging Congress Annual Congress. Kyoto, JP.
2010. 4D-MDCT: a radiologic imaging technique for anatomical localization and diagnosis of parathyroid tumors. Conference. European Congress of Radiology. Vienna, AT.
2009. Protease-sensing molecular optical imaging of human carotid atheromata to complement anatomy-based imaging. Conference. World Molecular Imaging Congress. Montreal, CA.
2009. Molecular imaging of retrograde neural transport using an optical agent. Conference. World Molecular Imaging Congress. Montreal, CA.
2009. Comparison of conventional and stereoscopic diffusion tensor imaging visualization techniques. Conference. American Society of Neuroradiology 47th Annual Meeting. Vancouver, CA.
2009. Imaging fast retrograde axonal transport. Conference. American Society of Neuroradiology 47th Annual Meeting. Vancouver, CA.
2008. In vitro optical imaging of host organ-specific tumor responses to radiation. Conference. World Molecular Imaging Congress. Nice, FR.
2008. Optimizing imaging of 3D multicellular tumor spheroids with fluorescent reporter proteins using confocal microscopy. Conference. World Molecular Imaging Congress. Nice, FR.
2008. An optically labeled agent for the molecular imaging of retrograde neural transport. Conference. World Molecular Imaging Congress. Nice, FR.
2008. Stereoscopic visualization of diffusion tensor imaging data: a comparative survey of several DTI visualization techniques. Conference. American Association of Physicists in Medicine. Houston, US.
2008. Optical Molecular Imaging. Invited. The University of Texas MD Anderson Cancer Center & Albert Einstein Symposium: Imaging In Cancer. Sao Paulo, BR.
2008. Image Guided Intervention in the Spine. Invited. The University of Texas MD Anderson Cancer Center & Albert Einstein Symposium: Imaging in Cancer. Sao Paulo, BR.
2007. HIF-1alpha expression in tumor spheroids can be induced by either low glucose or hypoxia, and can be associated with increased tumor cell motility. Conference. Society for Molecular Imaging and Academy of Joint Molecular Imaging Conference. Providence, US.
2007. Early experience with intraoperative MRI (brain suite) tumor resections. Conference. Richard Lende Winter Neurosurgery Conference jointly sponsored by the American Association of Neurological Surgeons. Snowbird, US.
2007. Rosai-Dorfman-Destombes disease in neuroradiology: imaging findings in 10 cases. Conference. Laakaripaivat (Finnish Medical Convention). Helsinki, FI.
2006. Four-dimensional computed tomography: a novel imaging modality for localization of parathyroid tumors. Conference. Society of Surgical Oncology Annual Meeting. San Diego, US.
2006. Four-dimensional computed tomography permits improved preoperative planning for directed parathyroidectomy. Conference. American Association of Endocrine Surgeons Annual Meeting. New York, US.
2005. Tomographic imaging with coded apertures from a single projection: experimental results. Conference. Institute of Electrical and Electronics Engineers Nuclear Science Symposium and Medical Imaging Conference, PR.
2005. Comparison of coded aperture, pinhole, and collimator nuclear imaging in the setting of stereotactic cerebral gene therapy. Conference. Society for Molecular Imaging 4th Annual Meeting. Cologne, DE.
2003. In vivo molecular imaging of stem cell transplantation in stroke. Conference. American Stroke Association 28th International Stroke Conference. Phoenix, US.

Formal Peers

2016. Imaging in Stroke: Patient to Population. Visiting. Imaging in Stroke: Patient to Population. Seoul.
2015. Frontiers in Neuroradiology. Invited. Frontiers in Neuroradiology. Pasadena, CA, US.
2013. Frontiers in Neuroradiology. Visiting. Frontiers in Neuroradiology. Dallas, TX, US.
2012. 2012 World Molecular Imaging Congress: Hot Topics. Invited. 2012 World Molecular Imaging Congress: Hot Topics. Seoul, KR.
2012. Stroke-related MR Findings: The Need for a Standard Reference Database. Invited. Stroke-related MR Findings: The Need for a Standard Reference Database. Seoul, KR.
2011. Molecular Neuroimaging. Invited. Molecular Neuroimaging. Boston, MA, US.
2011. Molecular Imaging of Neuronal Transport. Invited. Molecular Imaging of Neuronal Transport. Houston, TX, US.
2008. Molecular Neuroimaging and Board Review. Visiting. Molecular Neuroimaging and Board Review. Atlanta, GA, US.
2007. Minimally Invasive Spine Procedures: Oncological Applications and New Developments in Instrumentation. Invited. Minimally Invasive Spine Procedures: Oncological Applications and New Developments in Instrumentation. Lexington, KY, US.
2007. Case Presentation and Molecular Imaging in Neuroradiology. Visiting. Case Presentation and Molecular Imaging in Neuroradiology. Lexington, KY, US.
2004. Molecular Neuroimaging. Invited. Molecular Neuroimaging. Boston, MA, US.

Less

Grant & Contract Support

Date:	2023 - 2024
Title:	(5%) Machine Learning Estimation of Aggressive Disease to Guide Glioma Prognosis
Funding Source:	UTMDACC Institutional Research Grant
Role:	Co-PI
ID:	IRG

Date:	2022 - Present
Title:	(1%), PET/CT and Whole Body Magnetic Resonance Imaging (MRI) in Newly Diagnosed Acute Myeloid Leukemia (AML)
Funding Source:	Clinical trial funded by Race Oncology
Role:	Co-I

Date:	2022 - 2027
Title:	(30%) The Stereotactic Radiology-Pathology Trial II: Prospective Imaging-Pathologic Correlation in Glioma
Funding Source:	NIH/NCI
Role:	PI
ID:	1R01CA266086-01A1

Date:	2021 - 2026
Title:	Potentiation of Anti-Angiogenic Therapy by Inhibitors of Energy Metabolism
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R01CA262072-01

Date:	2021 - 2023
Title:	(10%). An Information-Theoretic Approach to HP Signal Acquisition In Brain
Funding Source:	NIH/NCI
Role:	Investigator
ID:	R21CA249373-01A1

Date:	2021 - 2026
Title:	AI-Enabled WHO Grade Estimation to Guide Accurate Biopsy in Gliomas
Funding Source:	NIH
Role:	Co-I
ID:	1R01CA259105-01

Date:	2021 - 2023
Title:	(0.5%). Syngo Virtual Operations Cockpit
Funding Source:	Siemens Medical Solutions USA
Role:	Collaborator
ID:	57826

Date:	2021 - 2022
Title:	AI-Enabled Tools For Improving the Brain Cancer Neuroimaging Pipeline
Funding Source:	InformAI- NIH SBIR
Role:	PI
ID:	PA-20-260

Date:	2020 - 2022
Title:	An Information-theoretic Approach to HP Signal Acquisition in Brain
Funding Source:	NIH NCI
Role:	Co-PI
ID:	1R21CA249373-01A1

Date:	2020 - 2024
Title:	Imaging Biomarkers for Glioma: the Stereotactic RadPath Trial
Funding Source:	NIH
Role:	PI

Date:	2019 - 2024
Title:	(4%) Development and Dissemination of Clinical CEST MRI Acquisition and Analysis Method for Cancer Imaging Applications
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R01CA231513-01A1

Date:	2019 - 2023
Title:	(0%). Study of F18 Fluciclovine PET CT for Assessment of Glioblastoma Tumor Volume and Radiation Response
Funding Source:	UTMDACC Diagnostic Imaging Clinical Research Committee
Role:	Co-PI
ID:	2018-0869

Date:	2018 - Present
Title:	(0%). Dual Time Point FDG PET MR Imaging Optimization for the Evaluation of Brain Metastasis (PET-MRI)
Funding Source:	UTMDACC Diagnostic Imaging Clinical Research Committee
Role:	PI
ID:	2017-0435

Date:	2018 - 2020
Title:	(0%). Advanced CT Imaging Optimization for the Detection of Intracranial Metastasis
Funding Source:	UTMDACC Diagnostic Imaging Clinical Research Committee
Role:	Collaborator
ID:	2018-0303

Date:	2018 - 2023
Title:	Imaging-Pathologic and Imaging-Genomic Signatures for Glioma: Establishing Links between Imaging, Pathology and Genomics
Funding Source:	NIH
Role:	PI

Date:	2018 - 2023
Title:	Developing a Molecular Imaging Tool for the Objective Assessment and Monitoring of Chemotherapy-Induced Neuropathy for Clinical Translation
Funding Source:	NIH
Role:	PI

Date:	2018 - 2021
Title:	Imaging and Pathology Quantification of Glioma Heterogeneity
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Co-PI

Date:	2018 - 2021
Title:	Neurographic Imaging for the Objective Assessment and Monitoring of Chemo-Induced Neuropathy in a Transgenic Mouse Model
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	PI

Date:	2017 - 2023
Title:	Advanced CT Imaging Optimization for the Detection of Intracranial Metastasis
Funding Source:	Diagnostic Imaging Clinical Research Committee
Role:	Collaborator

Date:	2017 - Present
Title:	(0%). A Hyperpolarized Pyruvate MR Spectroscopy Imaging Trial for Glioma Patients: An exploratory first study at MD Anderson Cancer Center
Funding Source:	Brain Cancer SPORE Pilot Program
Role:	PI
ID:	P50CA127001

Date:	2017 - 2017
Title:	A Neurographic Imaging Agent to Allow Nerve-sparing Prostate Cancer Treatment
Funding Source:	Department of Defense (DOD) Prostate
Role:	PI

Date:	2017 - 2017
Title:	Combination anti-Vascular and anti-Metabolic Treatments for Brain Tumors with Imaging Guidance by Hyperpolarized MR-Spectroscopy
Funding Source:	Marnie Rose Foundation
Role:	PI

Date:	2017 - 2017
Title:	A Nerve Imaging Agent to Allow Nerve-sparing Prostate Cancer Treatment
Funding Source:	Department of Defense (DOD)
Role:	PI

Date:	2017 - 2017
Title:	Developing a Molecular Imaging Tool for Objective Assessment and Monitoring of Chemotherapy-Induced Neuropathy for Clinical Translation
Funding Source:	NIH/NEI
Role:	PI

Date:	2017 - 2017
Title:	Imaging-Pathologic and Imaging-Genomic Signatures for Glioma: Establishing Links between Imaging, Pathology and Genomics
Funding Source:	NIH
Role:	PI

Date:	2017 - 2017
Title:	Neurographic Imaging for the Objective Assessment and Monitoring of Chemo-Induced Neuropathy in a Transgenic Mouse Model
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	PI

Date:	2017 - 2017
Title:	The Neuron-Astrocyte Dyad, the Lactate Shuttle and Metabolic Brain Imaging with Hyperpolarized MR
Funding Source:	NIH Brain Initiative
Role:	PI

Date:	2016 - 2016
Title:	Hyperpolarized MR
Funding Source:	CPRIT High Risk High Impact LOI
Role:	PI

Date:	2016 - 2016
Title:	NO TITLE PROVIDED
Funding Source:	Brain SPORE Project Solicitation
Role:	PI

Date:	2016 - 2016
Title:	NO TITLE PROVIDED
Funding Source:	Brain Spore Development Research Project
Role:	PI

Date:	2016 - 2016
Title:	Developing a Molecular Imaging Tool for the Objective Assessment and Monitoring of Chemotherapy-Induced Neuropathy
Funding Source:	CPRIT ETRA
Role:	PI

Date:	2016 - 2016
Title:	An Imaging-Pathologic-Genomic Signature for Glioma: Establishing Links between Imaging, Pathology and Genomics
Funding Source:	CPRIT IIRA
Role:	PI

Date:	2016 - 2016
Title:	NO TITLE PROVIDED
Funding Source:	ASNR Comparative Research
Role:	PI

Date:	2015 - 2016
Title:	Linking Imaging and Biology in Brain Tumors
Funding Source:	Moonshot/Translational Research on Brain Tumors
Role:	PI

Date:	2015 - 2015
Title:	Stereotactic Radiologic-Pathologic Brain Tumor Trial: Correlating Conventional MR, Perfusion, Diffusion, Spectroscopy, Hyperpolarized Spectroscopy and PET Imaging data to Pathology, Immunohistochemistry, Metabolomics, Proteomics and Genomics
Funding Source:	CABI MI2
Role:	PI

Date:	2015 - 2019
Title:	(10%). Hemorrhagic versus Calcific Brain Lesion Study
Funding Source:	GE Healthcare/CABI Award
Role:	PI

Date:	2015 - 2015
Title:	MR Imaging of Natural Killer Cell Immunotherapy
Funding Source:	CPRIT MIRA
Role:	PI

Date:	2015 - 2016
Title:	Neuroimaging in Cancer Care
Funding Source:	NIH R35
Role:	PI

Date:	2015 - 2016
Title:	(10%) Understanding the Heterogeneity of Gliomas: Image-Guided biopsy Correlations to Pathology, Metabolomics, Proteomics and Genomics
Funding Source:	NIH R01
Role:	PI

Date:	2015 - 2015
Title:	A Molecular Imaging Marker to Prevent Radiation Induced Spinal Cord Injury
Funding Source:	DoD Spinal Cord Injury
Role:	PI

Date:	2015 - 2016
Title:	(0%). Predicting Radiation-Induced Cord Myelopathhy Using a Molecular Imaging Readout of Retrograde Axonal Transport to Predict Myelopathy
Funding Source:	Center for Radiation Oncology Research Seed Funding Program
Role:	PI

Date:	2015 - 2015
Title:	NO TITLE PROVIDED
Funding Source:	NIH CIPN
Role:	PI

Date:	2015 - 2015
Title:	Preventing Radiation Therapy Damage to the Spinal Cord: Using Molecular Imaging as a Biomarker to Individualize Therapy
Funding Source:	NIH Spine Radiation
Role:	PI

Date:	2015 - 2016
Title:	Understanding the Heterogeneity of Gliomas: Image-Guided Biopsy Correlations to Pathology, Metabolomics, Proteomics and Genomics
Funding Source:	NIH
Role:	PI

Date:	2015 - 2015
Title:	Molecular Imaging as a Biomarker for Amyoytrophic Lateral Sclerosis
Funding Source:	DoD ALS
Role:	PI

Date:	2015 - 2015
Title:	Preventing Radiation Therapy Damage to the Spinal Cord: Using Molecular Imaging as a Biomarker to Individualize Therapy
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT) IIRA
Role:	PI

Date:	2015 - 2015
Title:	Preventing Radiation Therapy Damage to the Spinal Cord: Using Molecular Imaging as a Biomarker to Individualize Therapy
Funding Source:	DoD Spinal Cord Injury BAA
Role:	PI

Date:	2014 - 2015
Title:	(0%). Radiologic Pathologic Correlation on Stereotactic Biopsies in Glioma Patients
Funding Source:	MDA IRG Patient Oriented Award
Role:	PI

Date:	2014 - 2014
Title:	Retinography: Molecular Imaging to Understand the Mechanisms of Blindness
Funding Source:	MDA IRG Basic Science Award
Role:	PI

Date:	2014 - 2014
Title:	Finding the Borders of Gliomas with Advanced MR Imaging
Funding Source:	Brain Spore Developmental Research Grant
Role:	PI

Date:	2014 - 2014
Title:	Preventing Radiation Therapy Damage to the Spinal Cord: Using Molecular Imaging as a Biomarker to Individualize Therapy
Funding Source:	Center for Radiation Oncology Research
Role:	PI

Date:	2014 - 2014
Title:	(0%) A New Treatment for Brain Tumors: Targeting Tumor Metabolism with Glucose-based Therapeutic Agents and Monitoring Treatment Response with Hyperpolarized MR-Spectroscopy Recently appointed PI/Coordinator following the departure of Dr. Conrad, after re-writing of the project as: “Targeting the Glycolytic Pathway in the Therapy of Glioma, with Imaging Feedback of Efficacy by Means of Hyperpolarized MR Spectroscopy”
Funding Source:	Rose Foundation
Role:	PI

Date:	2014 - 2011
Title:	Understanding the Molecular Basis of Chemotherapy-Induced Neuropathy Caused by Oxaliplatin
Funding Source:	MDA Knowledge Gap Award
Role:	Co-I

Date:	2014 - 2014
Title:	Advanced MR as a Biomarker for Glioma: Detection, Prognosis and Monitoring
Funding Source:	MDA Knowledge Gap Award
Role:	PI

Date:	2014 - 2014
Title:	Ultrasound-guided Cryoablation of Papillary Thyroid Carcinoma Lymph Node Metastases in the Neck
Funding Source:	Thyroid Spore Developmental Research Project
Role:	Co-I

Date:	2014 - 2014
Title:	(0% support). Molecular Neurographic Imaging to Preserve Genital Nerve Function in Prostate Cancer
Funding Source:	MDACC-Washington University p50 Molecular Imaging Center Pilot Project Program
Role:	PI

Date:	2014 - 2015
Title:	Preserving Genital Nerve Function in Prostate Cancer: Imaging with a Molecular Imaging Agent
Funding Source:	M D Anderson Minimally Invasive and New Technology in Oncologic Surgery
Role:	Co-I

Date:	2014 - 2014
Title:	Preventing Radiation Therapy Damage to the Spinal Cord: Using Molecular Imaging as a Biomarker to Individualize Therapy
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	PI

Date:	2014 - 2014
Title:	Preserving Genital Nerve Function in Prostate Cancer: Neurographic Imaging with a Molecular Imaging Agent
Funding Source:	CPRIT High Impact/High Risk Research Award
Role:	Co-PI

Date:	2013 - 2014
Title:	Reducing the Impact of Chemotherapy-Induced Neuropathies on Cancer Patients: Understanding the Molecular Mechanisms of Disease
Funding Source:	Mike Hogg Fund
Role:	Co-I

Date:	2012 - 2014
Title:	(0% support). Characterization of Calcium and Iron Solutions using Gemstone Spectral Imaging CT to distinguish between Hemorrhagic and Calcific Lesions
Funding Source:	Center for Advanced Biomedical Imaging
Role:	Co-I

Date:	2012 - 2012
Title:	NO TITLE PROVIDED
Funding Source:	Howard Hughes Medical Institute (HHMI)
Role:	PI

Date:	2012 - 2012
Title:	Preserving Genital Nerve Function in Prostate Cancer: Neurographic Imaging with a Molecular Imaging Agent
Funding Source:	Prostate Cancer Foundation
Role:	PI

Date:	2012 - 2017
Title:	(0%). Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
Funding Source:	MD Anderson Clinical Research Finance Molecular Evaluation and Biopsy Related Support
Role:	PI

Date:	2011 - 2011
Title:	(12% effort). Clinically Practical Whole Body MRI of Prostate Cancer Metastasis
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Collaborator
ID:	RP120375

Date:	2011 - 2016
Title:	Molecular Imaging of Retrograde Nerve Transport
Funding Source:	NIH/NINDS
Role:	PI
ID:	5 R01 NS070742 02

Date:	2011 - 2011
Title:	(0% effort). Enhancing Quality of Life in Cancer Survivors by using Molecular Imaging to Prevent, Diagnose and Treat Nerve Injury
Funding Source:	The University of Texas MD Anderson Survivorship Institutional Grant
Role:	PI

Date:	2011 - 2012
Title:	(2% effort). Molecular Imaging of Treatments for Oxaliplatin Neurotoxicity
Funding Source:	The Mike Hogg Fund
Role:	PI
ID:	05-05-04032

Date:	2011 - 2021
Title:	(0%). Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
Funding Source:	MD Anderson Diagnostic Imaging Clinical Research Committee
Role:	PI
ID:	DICRC-04-2010

Date:	2010 - 2010
Title:	Clinically Practical Whole Body MRI of Prostate Cancer
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Collaborator
ID:	10709748

Date:	2010 - 2010
Title:	(5% effort). DCE/DW-MR and PET/CT Imaging Biomarkers: Optimization, Translation, and Validation
Funding Source:	U01 Application
Role:	Collaborator

Date:	2010 - 2012
Title:	(0% effort funded). Bridge Funding: Molecular Imaging of Retrograde Nerve Transport
Funding Source:	The University of Texas MD Anderson Cancer Center
Role:	PI

Date:	2010 - 2010
Title:	Bridge Funding, through chair of Dr. William A Murphy: Molecular Imaging of Retrograde Nerve Transport
Funding Source:	John S Dunn, Sr. Distinguished Chair in Diagnostic Imaging
Role:	PI

Date:	2009 - 2010
Title:	(5% effort). Imaging Retrograde Axonal Transport in Spinal Cord Injury using a Molecular Tracer
Funding Source:	Christopher and Dana Reeve Foundation
Role:	PI
ID:	1-2010-9600038

Date:	2009 - 2009
Title:	(10% effort). Spinal Cord Injury Research Program, Exploration-Hypothesis Development Award: Molecular Imaging of Retrograde Nerve Transport in Spinal Cord Injury
Funding Source:	Department of Defense (DOD)
Role:	PI

Date:	2009 - 2009
Title:	(20& effort). Molecular Imaging of Nerve Transport
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	PI
ID:	RFA R-10-I1

Date:	2009 - 2009
Title:	Imaging Cranial Nerves II, VII and X to Enable Nerve Sparing Cancer Treatments
Funding Source:	CPRIT Letter of Intent
Role:	PI

Date:	2009 - 2010
Title:	(15% effort). Image Localization for Pathologic Correlation of Delta-24-RGD
Funding Source:	NIH/NCI
Role:	Co-I

Date:	2009 - 2009
Title:	(10% effort). Molecular Imaging Technologies to Allow Image Guided Therapy for Cord Tumors
Funding Source:	Cord Foundation Research Grant Application
Role:	PI

Date:	2009 - 2009
Title:	(10% effort). Neurofibromatosis New Investigator Award: Molecular Imaging of Retrograde Nerve Transport in Neurofibromatosis
Funding Source:	Department of Defense (DOD)
Role:	PI

Date:	2009 - 2009
Title:	Prostate Cancer Research Program
Funding Source:	DOD/Congressionally Directed Medical Research Programs (DOD/CDMRP)
Role:	PI

Date:	2008 - 2009
Title:	(10% effort). Molecular Imaging of Genital Nerves: Preserving Erectile Function during Prostate Cancer Treatment
Funding Source:	Prostate Cancer Foundation
Role:	PI

Date:	2008 - 2009
Title:	(5% effort). Foundation Fellowship in Basic Science Research: Molecular Imaging of Fast Axonal Transport
Funding Source:	Bayer/NER
Role:	PI

Date:	2008 - 2008
Title:	(5% effort). Neurofibromatosis New Investigator Award: Molecular Imaging of Retrograde Nerve Transport in Neurofibromatosis, Department of Defense (DOD)
Funding Source:	Department of Defense (DOD)
Role:	PI

Date:	2007 - 2007
Title:	(20% effort). Outlining the Borders of Gliomas with a Novel Imaging Tracer: [18F]-1-Amino-3-fluoroCycloButane-Carboxylic Acid (FACBC)
Funding Source:	Sontag Foundation Career Development Award
Role:	PI

Date:	2006 - 2009
Title:	(20%). Molecular Imaging of Retrograde Nerve Transport
Funding Source:	The University of Texas MD Anderson Cancer Center
Role:	Principal Investigator-MDACC

Date:	2006 - 2006
Title:	(3%). Molecular Imaging of a Nerve Imaging Agent in Rats
Funding Source:	The Mike Hogg Fund
Role:	PI

Date:	2006 - 2006
Title:	Studying the Efficacy of Anti-cancer Drugs using Multi-modality Imaging in Small Animal Models of Cancer: Predicting Early Response to AZD8931 (ErdB2/EGFR Dual Inhibitor)
Funding Source:	AstraZeneca
Role:	PI

Date:	2006 - 2006
Title:	Molecular Imaging of Fast Axonal Transport
Funding Source:	Radiological Society of North America Seed Grant
Role:	PI

Date:	2006 - 2016
Title:	Outlining the Borders of Infiltrative Gliomas with a Novel PET Tracer [18F]-1-Amino-3-fluoroCycloButane-1Carboxylic Acid (FACBC)
Funding Source:	Goldhirsch Foundation
Role:	PI

Date:	2005 - 2005
Title:	Molecular Imaging of Fast Axonal Transport
Funding Source:	American Society of Neuroradiology
Role:	PI

Date:	2005 - 2005
Title:	Developing a Functional Nerve Imaging Agent
Funding Source:	Internal Review Board for Texas Advanced Research Program
Role:	PI

Date:	2005 - 2005
Title:	The Fate of Opsokines Conjugated to Tumor Cells in Rodents
Funding Source:	Genetrix, Inc
Role:	PI

Date:	2004 - 2004
Title:	Molecular Imaging of Fast Axonal Transport
Funding Source:	Neuroradiology Educational and Research Foundation, American Society of Neuroradiology
Role:	PI

Date:	2003 - 2004
Title:	Imaging of Stem Cell Recruitment to Stroke
Funding Source:	Radiological Society of North America Seed Grant
Role:	PI

Date:	2002 - 2004
Title:	Imaging Viral Therapy to Brain Tumors
Funding Source:	National Brain Tumor Association Fellowship Award
Role:	PI

Date:	2001 - 2006
Title:	Small Animal Imaging Resource Grant
Funding Source:	NIH
Role:	Investigator
ID:	1-R24-CA92782-01

Date:	2000 - 2001
Title:	Viral Gene Delivery to Highly Selective Regions in the Brain through Precision High Frequency Focused Ultrasound
Funding Source:	Partners Radiology Research Award
Role:	Principal Investigator-MDACC

Date:	1996 - 2006
Title:	(20%). Gene Therapy for Brain Tumors: Project 3, Molecular Imaging of Gene Expression
Funding Source:	NIH
Role:	Investigator
ID:	2-PO1-CA69246-05

Date:	1995 - 1996
Title:	(0%). R-R Variability in Healthy Young Male Human Subjects Undergoing General Anesthesia
Funding Source:	NAVKOM Student Investigator Award, NAVKOM
Role:	PI

Title:	(0%). Development of Unconventional MRI Approaches to Imaging Cancer Immunotherapy
Funding Source:	CABI MI2 (Bankson/Sokolov)
Role:	Collaborator

Title:	Axonal transport as a biomarker for the early detection and treatment of chemo induced retinopathy
Funding Source:	Hesi Thrive Foundation
Role:	Co-I

CV information above last modified March 03, 2025

Dawid Schellingerhout, MBChB, BSc (Hons) (Physiology), CPE, MBA

About Dr. Schellingerhout

Present Title & Affiliation

Primary Appointment

Dual/Joint/Adjunct Appointment

Research Interests

Clinical Interests

Education & Training

Degree-Granting Education

Postgraduate Training

Board Certifications

Experience & Service

Academic Appointments

Administrative Appointments/Responsibilities

Other Appointments/Responsibilities

Institutional Committee Activities

Honors & Awards

Professional Memberships

Selected Publications

Peer-Reviewed Articles

Invited Articles

Other Articles

Abstracts

Book Chapters

Selected Presentations & Talks

Local Presentations

Regional Presentations

National Presentations

International Presentations

Formal Peers

Grant & Contract Support

Patient Reviews

Related Links

Schellingerhout Laboratory

Help #EndCancer

Dawid Schellingerhout, MBChB, BSc (Hons) (Physiology), CPE, MBA

About Dr. Schellingerhout

Present Title & Affiliation

Primary Appointment

Dual/Joint/Adjunct Appointment

Research Interests

Clinical Interests

Education & Training

Degree-Granting Education

Postgraduate Training

Board Certifications

Experience & Service

Academic Appointments

Administrative Appointments/Responsibilities

Other Appointments/Responsibilities

Institutional Committee Activities

Honors & Awards

Professional Memberships

Selected Publications

Peer-Reviewed Articles

Invited Articles

Other Articles

Abstracts

Book Chapters

Selected Presentations & Talks

Local Presentations

Regional Presentations

National Presentations

International Presentations

Formal Peers

Grant & Contract Support

Patient Reviews

Request an Appointment

Related Links

Schellingerhout Laboratory

Clinical Trials

Help #EndCancer

Give Now

Donate Blood

Volunteer